University of Vermont

UVM ScholarWorks
Graduate College Dissertations and Theses

Dissertations and Theses

2019

Clinical Evidence Technologies and Patient Care
Marianne D. Burke
University of Vermont

Follow this and additional works at: https://scholarworks.uvm.edu/graddis
Part of the Health and Medical Administration Commons, and the Library and Information Science
Commons

Recommended Citation
Burke, Marianne D., "Clinical Evidence Technologies and Patient Care" (2019). Graduate College
Dissertations and Theses. 1022.
https://scholarworks.uvm.edu/graddis/1022

This Dissertation is brought to you for free and open access by the Dissertations and Theses at UVM
ScholarWorks. It has been accepted for inclusion in Graduate College Dissertations and Theses by an authorized
administrator of UVM ScholarWorks. For more information, please contact scholarworks@uvm.edu.

CLINICAL EVIDENCE TECHNOLOGIES AND PATIENT CARE

A Dissertation Presented

by
Marianne D. Burke
to
The Faculty of the Graduate College
of
The University of Vermont

In Partial Fulfillment of the Requirements
for the Degree of Doctor of Philosophy
Specializing in Clinical and Translational Science
May, 2019

Defense Date: March 18, 2019
Dissertation Examination Committee:
Benjamin Littenberg, M.D., Advisor
John King, M.D., Chairperson
Julie Lin, M.D.
Charles MacLean M.D.
Cynthia J. Forehand, Ph.D., Dean of the Graduate College

ABSTRACT
Clinical evidence technologies (CETs) are information sources derived from
medical research literature that may assist health care providers in continued learning,
decision-making, and patient care. Examples of CETs include: MEDLINE/PubMed and
Cochrane Reviews, research journal literature, print and electronic medical texts, clinical
topic summaries, guidelines, and interactive decision tools. Clinicians utilize CETs to
find answers to questions that arise during patient care. However, it was unclear if CETs
had a measurable impact on provider practice or patient outcomes.
A literature review identified twenty-two articles evaluating CETs’ impact.
Study designs included surveys, observational studies, randomized controlled trials and
quasi-experimental methods. The review revealed mixed evidence of CET impact on
provider-level outcomes such as improved diagnoses and treatments, and on patient level
outcomes such as length of hospital stay and mortality. Additional research was needed to
determine whether certain CETs or CET types have impact on patient care outcomes in
clinically targeted areas.
We conducted a cluster-randomized controlled trial (CRCT) to evaluate the
effect of a dermatology-focused CET (VisualDx) when used by primary care providers.
We found no difference in the patient skin disease outcomes of resolution of symptoms
and return visits for the same problem in that trial. Thirty-two PCPs and 433 patients
participated. In proportional hazards modelling adjusted for provider clusters, the time
from index visit to skin problem resolution was similar in both groups (Hazard
Ratio=0.92; 95% Confidence Interval (CI)=0.70, 1.21; P=0.54). Patient follow-up
appointments did not differ significantly between groups (Odds Ratio=1.26; CI=0.94,
1.70; P=0.29).
In a follow up mixed-methods study, we sought to understand why VisualDx did
not make a difference. All CRCT provider participants were surveyed about their
experience in the trial. VisualDx users (intervention arm) were interviewed about their
experience using the CET. Ease of access and usefulness for patient communication
facilitated successful use while irrelevant search results and use of other sources were
barriers. Although PCPs reported benefits, they did not perceive the CET as useful often
enough to motivate using it frequently or exclusively, thereby reducing the likelihood of
it making a difference in the problem resolution and return appointment outcomes.
There was no difference in skin problem resolution or number of follow-up
visits when PCPs used VisualDx. PCPs did not perceive VisualDx as “useful” often
enough for to use it frequently, or exclusively, thereby reducing the likelihood of this
CET making a difference in patient-level outcomes.
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Effects of Clinical Evidence Technologies on Provider Practice
and Patients: A Literature Review
1.1 Abstract
Background: Barriers to utilizing the evidence from research persist in health care. The
influence of the evidence-based medicine model and the availability of multiple evidence
source types may have reduced barriers to health care providers’ use of evidence sources
and increased the possibility of their impact on clinical practice and patient care
outcomes.
Objective: To evaluate the impact of clinical evidence technologies on clinical practice
and patient outcomes.
Methods: Research evaluating a variety of clinical evidence technologies was identified
through iterative searches in MEDLINE, Google Scholar, and reference lists. Studies
involving clinical evidence technologies (CETs) and measuring an impact on clinician
practice and patient outcomes were eligible for inclusion.
Results: Four clinical evidence technology types were identified in 22 studies that
investigated the impact of clinical evidence technologies on clinical practice and patient
outcomes. Technology types included multiple CETs in combination, multiple CETs
searched by an intermediary, single CETs, and education in CET use. No consistent
pattern of results was found across the studies. Positive results were found in randomized
controlled trials, quasi-experimental studies of single CETs, and observational studies
utilizing large data sets. Other quasi-experimental and randomized trials were negative.
1

Discussion: Serious design flaws were noted in several studies. There is conflicting
evidence that CETS either individually or collectively improve provider-level or patientlevel health care outcomes.
Conclusion: There is mixed evidence supporting an association of CET use with
improved patient care. Research with rigorous study designs is needed to determine the
effect of clinical evidence technologies on clinical practice and patient-level outcomes.
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1.2 Introduction
The information needs and information seeking behaviors of clinicians are well
documented. A 2007 literature review of 36 studies of clinical information needs of
physicians covered literature from 1999-2005. The review summarized their reported
information needs as diagnosis related questions 10-40%, treatment information 14 –
60%, and drug therapy 15-60% of information needed [1]. A 2013 review of 24 peerreviewed studies on information needs and information-seeking behavior found similar
proportions of need for diagnosis information, drug information, and general treatment
information needs. The same review confirmed that clinicians utilize diverse information
sources including databases, textbooks, journal articles, the internet, and technologies
integrated within the electronic health record [2].These systematic reviews also support
the notion that clinicians, especially primary care providers, seek information regularly to
support patient care. Obstacles to answering clinical questions and information
acquisition have been reported for decades. Poor technology access, lack of available
information sources, lack of relevant evidence in chosen source, time constraints, and
lack of institutional support are reported as reasons for clinicians’ failure to use evidence
sources in patient care [3-6].
With the emergence of evidence sources that may reduce time and access
barriers such as point-of-care clinical summaries, optimized citation databases, and open
access journal literature, it is reasonable to consider if they have a positive impact on
clinical practice and patient care outcomes. We sought to identify research on the impact
of clinical evidence technologies (CETs) use to improve clinical practice and patient
3

outcomes, and to assess the quality and findings of the research identified.
1.2.1 Clinical Evidence Technologies Definition
We use the term “clinical evidence technologies (CETs)” in this review to apply
to information sources derived from the medical research literature that may assist health
care providers in their continued learning, decision-making, and patient care. We define
the term “evidence” as “Grounds for belief;…the available body of facts or information
indicating whether a belief or proposition is true or valid” [7]. Evidence in this context
emphasizes the medical/ scientific knowledge-base and the authority it is based upon. We
use “technology” in the sense of the application of knowledge for practical purposes [7].
In recent decades, technology has been thought of as pertaining to electronic devices
only, but any device with practical purpose is a technology, so we considered printed and
electronic materials, content and citation databases, educational programs, and literature
search interventions as technologies.
Other terms have been used in the health care literature for similar or
overlapping health care related technologies. “Knowledge-based information” (KBI) is
the term used by the Joint Commission on Accreditations of Health Organizations. The
2018 Comprehensive Accreditation Manual for Hospitals standard (IM.03.01.01) requires
that knowledge-based information resources be “available, current, and authoritative” [8].
The manual has described knowledge-based information as that “found in the clinical,
scientific, and management literature” [9].
Examples of CETs include citation databases, such as MEDLINE/PUBMED and
Cochrane reviews, the published research journal literature, print and electronic medical
4

texts, clinical topic summaries, and technologies that incorporate clinical reference topics
with diagnostic tools. While some CETS, such as decision-support and point-of-care
summaries, may be oriented toward patient care episodes, others have more diverse goals
and uses such as promulgation of research, professional clinical education, and life-long
learning. CETs may include use of a singles CET or multiple CETs in combination such
as the variety of resources available from a hospital medical library or accessed from an
institutional website.
1.2.2 Provider-Practice Level vs. Patient-Level Outcomes Definitions
This review identifies the impact of CETs on health care outcomes at the
provider practice and patient levels. Provider-level outcomes are the intermediate steps of
management, i.e. diagnosis or treatment decisions, safety measures adopted, or the
avoidance of adverse events [10].
Patient-level outcomes are those outcomes that are the result of care from the
patient perspective including mortality, symptoms, health status, impact on activity,
perceived benefit, and costs to the patient such as length of hospital stay and charges for
care. [11].
Several literature reviews have focused on health information technologies in
general in health care [12], medical librarian services [13], and clinical decision support
systems [14], but none have focused on the spectrum of literature-derived CETs and their
impact on provider practice and patient-level outcomes. Therefore, we sought to identify
research evaluating CETs and to assess it for quality and validity of evidence of impact
on clinical management and patients.
5

1.3 Objectives
This review aims to identify research studies and assess evidence on the impact
of clinical evidence technologies, as used by clinicians, on clinical management and
patient outcomes. The specific objectives are to identify and assess research on 1) the
impact of use of CETs on provider management of patients and 2) the impact of CETs on
patient-level outcomes.
1.4 Methods
We identified peer-reviewed journal articles in which an impact of clinical
evidence technologies on clinical management or patient outcomes was evaluated.
1.4.1 Literature Search Methods
We searched MEDLINE/PubMed and Google Scholar for peer-reviewed articles
encompassing the impact of knowledge-based information sources and services (CETs)
on practice and patient outcomes. Two concepts were combined in the searches: 1) terms
to identify clinical evidence technologies and 2) terms to identify impacts on patient care
outcomes at the provider practice and patient levels.
Subject headings or terms employed to retrieve the articles on clinical evidence
technologies in MEDLINE included “Databases, Bibliographic”, or “Databases, Factual,
or “Information Services” or “Library Services” or “Libraries, Medical” OR “Information
Storage and Retrieval/utilization” or “Hospital Information Systems” or “Decision
Support Systems, Clinical”
Subject headings and terms employed to identify impacts on clinician level
6

practice outcomes and patient-level outcomes included: “Physician's Practice Patterns” or
“Information-Seeking Behavior” or “Evidence-Based Medicine/Methods” or “Patient
Care” or “Diagnostic Accuracy” or “Quality of Health Care”, or “Quality Assurance” or
“Referral patterns” or “Guideline Adherence” or “Hospital Mortality” or “Length of
Stay”, or “Referral” or “Treatment Outcomes”.
Articles were also identified by manual review of reference lists of identified
articles and literature reviews on related topics. Additional searches were conducted in
MEDLINE and Google Scholar using terms that described articles identified in manual
reviews. The subject terms “Outcomes and Process Assessment”, “Diagnostic Errors”,
and “Patient Readmission” did not yield additional articles.
1.4.2 Study Selection
We did not limit inclusion to a particular study design, such as randomized
trials, but were open to various study designs, including surveys, observational,
interrupted time series (before and after), randomized, cohort, case control, and
comparative effectiveness studies. Data were obtained from provider or patient selfreport, patient records, and insurance claims if a practice or patient level outcome was
measured. Studies with clinicians of any type, including physicians, nurses or trainees,
who were involved in patient care, were included.
Articles were excluded if they 1) made no reference to a medical knowledgebased or literature-derived evidence source or content, 2) focused on undergraduate
medical students alone, (3) reported provider knowledge, attitude, behavior, or
satisfaction outcomes only, or 4) presented no data measuring clinically-relevant
7

outcomes.
1.4.3 Data Extraction and Analysis
Details from the studies were extracted and appraised by the first author. A
second reviewer assisted with the appraisal of study designs, outcomes, and findings. We
extracted the following data from each included article: 1) Study first author and date of
publication, 2) Study design and method, 3) Participants and sample size, 4) Setting, 5)
Data source, 6) CET(s) assessed, 7) Outcomes measured, and, 8) Findings. The author
reviewed the articles and judged inclusion and exclusion based on the pre-set criteria. We
planned a descriptive synthesis of the data extracted, rather than statistical analysis
because of the expected heterogeneity of study designs, CETs, and outcomes measured in
the reviewed articles.
1.5 Results
An initial MEDLINE literature search returned 72 articles that warranted abstract
review or full reading to determine eligibility. Eleven articles from that search were
retained and included in this review. Of the excluded articles, about one-third were
excluded because they lacked provider or patient outcomes, one-third lacked an
evaluation of a literature derived CET, and others reported no data on primary outcomes.
Five were literature reviews whose reference lists were examined. The additional eleven
included articles were identified through the reference lists of relevant articles and related
literature reviews, keyword and natural language searches in Google Scholar, and the
recommendation of colleagues. Twenty-two articles evaluating four CET types met all
inclusion criteria, including:
8

•

Two that assessed clinician use of multiple-evidence sources [15, 16];

•

Five that evaluated expert literature search services accessing multiple evidence
sources [17-21];

•

Two that assessed education in EBM methods (acquiring and appraising CET
evidence) interventions [22, 23];

•

Nine studies of a single commercially published or researcher developed product
[24-33]; and

•

Three studies that compared effectiveness of two CETs, or one CET and a
decision support tool [34-36].
Studies were further analyzed by outcome and data source categories including

clinician-reported impact of CETs, impact of CETs on provider practice with independent
data sources, and impact on patient-level outcomes also with independent data sources.
1.5.1 Provider-Reported Outcomes of CETs
Nine studies measured clinician perception of the evidence retrieved from CETs
on their practice. Study designs include large sample cross-sectional surveys, pre- and
post- surveys, and randomized trials. Provider-level outcomes included diagnosis, and
treatment impacts, perceived overall impact on patient care, and time saved.
(See Table 1.1)
Multiple CETs Used by Clinicians
Two multi-site cross-sectional clinician surveys evaluated the impact of multiple
medical library-provided CETs on patient care. Marshall et al, surveyed over 16,000
9

health care providers, including physicians, residents, advanced practice nurses and
others, employed at 118 hospitals. Participants were asked to recall a recent patient care
incident and to answer questions about how use of library provided information sources
had (or had not) affected patient care in that event [15]. Seventy-five percent of the
respondents indicated that patient care was definitely or probably handled differently due
to an evidence source used. In addition, avoidance of patient misunderstanding was
reported by 23%, and avoidance of additional tests by 19%. Misdiagnoses were avoided
by 13%, and mortality avoided by 6% in the recalled incident.
Another cross-sectional multi-institutional study surveyed 328 health care
providers, including 203 physicians, in four hospitals in Colorado and Missouri of
varying size (Sievert, 2011) [16]. In that study, 87% of attending physicians, 91% of
residents and physician assistants, and 67% of nurses reported they had changed
management of a patient with use of library-sourced CETs. More than four-fifths of the
physician sub-group confirmed decision (84%), changed advice to patients (36%), and at
least 70% modified diagnosis, therapy, and tests ordered.
Multiple CETs Searched by Intermediary
Three studies evaluated the impact of multiple CETs on provider practice
outcomes when an intermediary literature search by an expert (such as a medical
librarian) was performed.
A randomized controlled trial by McGowan et al. (2008) compared the
effectiveness of a search by a medical librarian consult service, called JIT (Just-in-Time),
to primary care providers (PCPs) self-search for answers to their clinical questions. [17].
10

PCPs’ queries were randomized to the librarian search or self-search when the physician
posed a clinical question to the central service. The 88 participants presented 1,889
queries and rated each query’s results. The utility of evidence found for clinical decisionmaking and the time to complete the search were the outcomes measured. Twenty percent
of librarian searches resulted in improved practice and decision-making, compared to 5%
of physician self-searches. The librarian searches answered questions in an average of
13.7 minutes compared to 20.3 minutes (95% CI 18.7, 21.86) for the self-search. In this
study, evidence searches conducted by medical librarians produced more patient-care
relevant results in less time compared to physician searches. When a question was
randomized to provider self-search, the PCPs conducted searches for only 40% of the
questions.
Mulvaney (2008) conducted a randomized controlled trial in which clinician
consult requests from four inpatient services were randomly assigned to a Clinical
Informatics Consult Service (CICS) staffed by trained clinical librarians, or no CICS
service [18]. Impacts on clinician actions regarding diagnoses and treatments were
measured. Different or new treatments resulted from 14.9% of requests to CICS consult
vs. 4.8% with no CICS, (OR 8.2 95% CI 1.04, 64.0). There were no significant
differences in diagnosis related actions. CICS librarians spent more time on the evidence
search, and presentation, 4 hours average, compared to clinicians who spent an average of
1.6 hours. Though the CICS service undoubtedly saved time of the physicians who did no
search themselves, the length of time reported for searching and filtering the literature in
both groups was remarkably long compared to the time measured in other studies,
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possibly limiting the generalizability of this service model. Also, some clinicians
requested a CICS consult but refused randomization. The search was conducted for them,
but their results were excluded from analysis, possibly reducing the impact of the CICS
intervention on urgent or complex cases.
A cross-over design study (Aitken, 2011) evaluated a librarian search and
education intervention with 50 resident participants who rotated through the control and
intervention groups [19]. A majority (74%) reported they changed treatment plan and
36% changed diagnoses based on the mediated search information. Although described as
a controlled trial, there were no baseline data on pre-intervention patient management
with CETs reported. With no outcome comparison with the control group, the value of
the outcomes reported with this sample size is limited.
Single CETs by Commercial Publisher or Institutional Developer
Five studies evaluated individual commercial publisher or institutionally
developed CETs with provider-reported data.
In a study evaluating DynaMed, a clinical topics summary, Alper et al (2005)
conducted a randomized controlled trial to determine the CETs effect on decisions and
time to find answers compared to usual sources [24]. Physicians were randomized per
question to use DynaMed or not. Among 46 PCPs, 54% found answers that changed
clinical decisions with DynaMed compared to 23% without (P=0.05). Median search
time was 4.7 minutes with DynaMed vs. 4.8 minutes with other sources (P=0.64). The
first author was the original developer of DynaMed, which is now owned by the
commercial publisher EBSCO Health.
12

Another study evaluated Quick Clinical, an institutionally developed CET
comprised of aggregated evidence sources with a single access point. In a 4 month trial of
Quick Clinical, 74% of 227 participating PCPs in Australia reported improved patient
care after using it an average of 10 times the first month [37]. After a year, usage
frequency dropped to three uses per month and reported treatment effects declined [38].
Comparative Effectiveness of CETs
Three studies compared effectiveness of variations of clinical evidence
technologies on practice outcomes. Grad and Pluye et al. compared practice outcomes of
a knowledge-based CET called CIRT (Clinical Information Retrieval Technology) that
included literature derived content, such as Cochrane reviews and InfoPoems (a clinical
topic summary), to a decision-support tool that included calculators and prediction rules
[35]. The calculator and reminder type tool was associated with practice improvement in
participant surveys more often than the more literature-based CIRT, in 25% vs 12% of
searches. When used together, 78% of links retrieved from both source types had a
positive practice impact.
A study by Del Fiol et al. (2008), compared the effectiveness of two versions of
the CET Micromedex in a randomized trial [36]. Both versions were accessed by means
of “Infobuttons” within the electronic health record (EHR). The control version included
links to the drug prescriber CET (Micromedex) as generally published, and the other
provided specific links to topics and performed imbedded searches within the CET. There
was no difference in clinical impact of each link type and no difference in time spent.
Participants reported high positive clinical impact in all sessions (62%) in both types.
13

Maviglia studied the use of drug medication information sources embedded in
an EHR by providers at 18 outpatient clinics that were randomized to either Micromedex
or Skolar MD, both commercially available drug information databases [34]. No
difference was reported for decision changes between groups. The CETs combined
answered the query in 84% of searches and resulted in a patient care decision change in
15% of searches.
In these provider-reported outcome studies, the overall impact of the
information sources on provider decisions was generally positive and, in a few cases,
statistically significant. Impacts on care management were reported by 75% or more of
participants in cross-sectional and multi-CET search studies. There were smaller effect
sizes, i.e. 20% impact on care, with intermediary search vs. about 5% impact with
provider self-searches. The difference in impact between variations of similar
information sources was generally not significant except compared to a calculator and
reminder tool.
1.5.2 Provider Practice-Level Outcomes with Independent Measures
Seven studies measured impacts on provider-level outcomes using independent
data from patient records or judged by specialist review. (See Table 1.2)
Five studies evaluated single published CETs, and two studies evaluated an EBM
methods education intervention. Study designs included before-and-after, and parallel
comparisons. Provider outcomes included impact on decision-making, diagnosis impacts,
medications and treatments prescribed, referrals or consults, and clinician time spent.

14

Single CET Evaluations with Independent Data
King (2007) evaluated use of a Clinical Evidence module imbedded in a
computerized-physician order entry (CPOE) system [28]. Pediatric inpatients diagnosed
with bronchiolitis comprised the sample of 147 patients admitted in a 6 month period
before, and 187 patients after implementation of the module. Entry of the bronchiolitis
diagnosis in the CPOE prompted the appearance of the CET with relevant evidence.
Primary outcomes measured were frequency of ordering antibiotics, bronchodilators, and
steroids. Length of hospital stay was also measured. In the post-implementation period,
22% of patients received antibiotics with the CET vs. 37% before, a relative decrease of
37% (P= 0.016), in-line with the CET evidence. There were no differences in
bronchodilators or steroids ordered and no difference in patient length of stay.
Barbieri (2015) evaluated VisualDx, an interactive diagnostic tool with images
and topic summaries [39], for impact on dermatology consults requested for inpatients
before and after the CET was implemented [33]. The number of consults requested per
month, and the rate of increase in consults were measured. Post-implementation the
absolute number of consults decreased non-significantly by median 4.6 per month
(P=0.75), and the rate of consults increased at the rate of one consult per month in both
periods (P=0.99).
Another evaluation of VisualDx measured inclusion of the correct final
diagnosis in the differential diagnosis list for patients initially diagnosed with cellulitis in
the emergency department (ED) by resident physicians with and without the CET. [26].
Records of 145 patients admitted to the ED in 2 hospitals were reviewed and, of those, 28
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(25%) were deemed misdiagnosed. The correct diagnosis was included in the differential
in 18 of 28 cases (64%) when VisualDx was used by a resident vs. correct diagnosis
included in the differential in only 4 of 28 cases (14%) by the ED admitting team without
VisualDx (P=0.003).
Evaluating a dermatology-relevant CET, Gulati assessed a skin cancer
information and education toolkit for impact on referral rates by General Practitioners in
England [31]. Over 20% of English general practitioners accessed the toolkit online
through a national physicians’ website in a six month period after it was deployed and
marketed. The toolkit included referral guidelines for suspected skin cancer. In the year
after toolkit introduction, there was no difference in referrals made to dermatologists by
GPs compared to the pre-toolkit year reported in a national referral database. Use of the
toolkit did improve GP confidence in skin cancer diagnosis according to a survey of those
who used it.
The fifth study evaluating a single CET examined UpToDate [40]. In this study
by Shimizu, researchers reviewed charts of 100 patients seen by general practitioners in
outpatient clinics of a Tokyo teaching hospital [32]. Of 100 patients, half were seen by
general practitioners (GPs) with access to UpToDate and half were seen by GPs without
access. Patient records were screened for correct diagnosis at the index visit to
ambulatory care. Decision of correct or incorrect diagnosis was determined by two author
investigators reviewing cases independently using an algorithm for error identification
described by Singh (2007) [41]. They found a 2% error rate in the UpToDate group of
patients, compared to the 25% error rate in the control group. It was unclear from the
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article how the physicians were equipped or not with UpToDate, how they were enrolled
in the study, and if the reviewers were blinded to the group allocation of physicians and
patients. While this study had independent validation of practice improvement, it lacked
information about randomization and blinding that limits confidence in its findings.
Education in EBM Methods
Education in evidence-based medicine methods includes training in retrieving
evidence from medical research literature, appraising it for quality, and applying it with
patients. Two studies assessed the impact of education in EBM methods on treatments
and tests ordered. The model in both was that participants would retrieve and appraise
evidence information from CETs to determine the best protocol. Straus et al. compared
physician orders at a community hospital for treatments before and after the education
[22]. After a seven-hour education session in EBM methods, resident physicians ordered
significantly more treatments validated with evidence from randomized-controlled trials
or meta-analysis evidence than before (42% pre- v.62% post; P=0.016).
Shuval et al compared PCP orders for tests and medications for certain
conditions pre- and post- a standardized curriculum intervention of five sessions plus
individualized practice site teaching [23]. The tests and treatment orders measured were
controversial in that the best evidence from the CETs taught in the intervention
recommended protocols that were infrequently followed. In this study, there was no
statistical difference (increase) in the proportion of evidence-based tests, such as vision
screening P=0.67), or medications, such as Lipitor (P=0.87), ordered after the education.
While the education interventions had conflicting results on the provider
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outcomes, both were associated with improved knowledge and skills in evidence
retrieval.
In the studies of CETs evaluated for impact on provider-level outcomes with
independent data sources, the findings were mixed. Four studies had positive results for
the primary outcomes measured (King, David, Shimizu, and Straus) and three had
negative, i.e., no difference, findings (Barbieri. Gulati, and Shuval).
1.5.3 Patient-Level Outcomes
Seven studies evaluated CETs with patient-level outcome measures. Three
evaluated expert intermediary searches of multiple CETs, and four evaluated single
commercially published CETs. Study designs included two observational studies, one
RCT, and five quasi-experimental study designs. Outcomes including length of stay,
mortality, quality indicators, readmission rate, charges, and hospital costs. (See Table
1.3)
Intermediary Evidence Search Impact
An intermediary evidence search conducted by an expert librarian or physician
was the CET intervention in three studies with patient-level outcomes. In a case-control
study by Banks (2007), 55 inpatient cases presented at Medicine morning report were
matched with 136 controls from the previous five years of hospital admissions [42]. A
medical librarian on the team conducted an evidence search on questions raised by
physicians concerning the cases. Cases and controls were matched on age, primary
diagnosis, and secondary diagnoses with up to 3 co-morbidities. Length of stay was
reduced by an average of two days with the evidence search support (P=0.023). Total
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charges for hospitalization were lower, but not significantly different (P=0.24), in the
intervention group, with a median difference of $1,392 between groups. There was no
difference in 30-day hospital readmission rate. It’s possible that events occurring outside
the study influenced the findings. The control group was drawn from patients from 1 – 5
years (2001 to 2006) prior to the cases. The downward trend of length of stay in U.S.
hospitals, occurring at the time could have influenced the positive LOS effect. In that
period AHRQ data appears to show that US national length of stay had declined among
Medicare beneficiaries, between 2006 and 2015 [43].
Similarly, Esparza conducted a study (2013) on the effect of a medical librarian
intermediary search on the patient outcomes of length of stay and 30-day readmission
rates [21]. The intervention arm included 252 patients admitted and treated by the
physician team with medical librarian support. The control arm included 1948 patients
treated by a second physician team with no support. This non-randomized study had a
parallel design, i.e. the intervention and control arms occurred concurrently, reducing the
likelihood of secular events influencing the results. However, LOS and hospital
readmission rates were actually higher in the intermediary search supported patients. LOS
was two days higher (median 6 days vs. 4 (P<0.001). Thirty-day readmission rates were
likewise higher, 19% of patients vs. 13%, P<0.001. The re-assignment of patient cases
from the intervention team to the control team may have biased the results against the
intervention. Patients admitted and treated by the intervention group who did not require
an evidence search, were “flipped” to the control group. Since literature searches were
usually requested for more complex cases, moving less complex cases to control may

19

have kept more serious cases in the intervention group leading to longer hospital stays
and readmissions.
A third study by Izcovich (2011) evaluated the intermediary search of multiple
CETs for questions arising from patient cases with a randomized controlled trial [20].
The mediated searcher in this study was an attending physician informatics specialist.
Patients were randomly assigned to a search supported group or an unsupported group for
6 months. Questions that arose in the intervention group patients were supported by an
evidence search in available evidence sources. Compiled information was sent to all
members of the intervention group team. Outcomes measured from patient record data
included mortality or transfer to ICU, readmission, and length of hospital stay. There was
a half-day difference in length of stay favoring control, but it was not statistically
significant (P=0.24). There were no differences between groups in the other primary
outcomes. In this study it appears that all cases stayed within the assigned intervention or
control group on the intention to treat principle.
Single CET Evaluations with Patient Outcomes
Four studies evaluated the association of single CETs with patient outcomes. UpToDate
was evaluated in two observational studies [29, 30]. Others evaluated were DXplain [27]
and Clinical Evidence [28] . Some of the Clinical Evidence (King) study findings were
reported earlier in the provider-level results. The length of stay outcome in that study is
also included here.
Two observational studies evaluated UpToDate by comparing patient outcomes
at hospitals with the CET and without it. The earlier (2008) study by Bonis compared
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outcomes in 424 hospitals that licensed UpToDate to 309 hospitals that did not license it
between 2000 and 2006 [29]. Hospital outcome data was taken from the proprietary
Thomson Top 100 Hospitals Survey database. Information on hospital licensees was
supplied by UpToDate, Inc. In that study Length of Stay was reduced 0.18 days
(P<0.001). Statistically significant differences were found for reduced complications
(P=0.048) and AHRQ patient safety indicators (P<0.001). There was no difference in
mortality between the hospital groups (P=0.34). Two authors of this research were
employed by UpToDate, Inc. (Bonis and Rind) and two others (Pickens and Foster) were
employed by Thomson Healthcare, the source of the hospital data and analysis. The study
was funded entirely by UpToDate, Inc.
In the second observational study on UpToDate (Isaac et al, 2012) patient
outcomes in hospitals with licenses to UpToDate were again compared to those without
licenses [30]. Outcomes compared were risk-adjusted lengths of stay, mortality rates, and
quality performance. Measures were derived from aggregate and individual hospital
Medicare and Medicaid insurance claims data. An UpToDate license in a hospital was
associated with shorter average length of stay compared to non-UpToDate hospitals (5.6
days versus 5.7 days; P< 0.001). Among six conditions such as stroke or hip fracture the
reduction of length of stay was 0.1 to 0.2 days (P<0.001) for each condition. Smaller
community hospitals were associated with larger effect sizes than large teaching
hospitals. This study was funded by UpToDate, Inc. also, but, according to the disclosure
statement, the corporation “had no role on study design, input into analyses presented, or
drafting or editing the manuscript.”
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Two other studies of individual CETs with patient outcomes include trials of
DXplain, a decision support system developed at Massachusetts General Hospital, and
the Clinical Evidence variant (BMJ Publishing) imbedded in the electronic medical
record described earlier. These CETs had interactive elements depending on provider
input, such as patient symptoms or lab values, characteristic of clinical decision support
systems.
The DXplain trial conducted in 2001-2002, (published in 2010) compared total
hospital charges, Medicare Part A charges, and LOS in diagnostically challenging cases
admitted before and after implementation of the DXplain tool in a large U.S. teaching
hospital [27]. In the intervention period, total charges averaged $1,281 less per patient,
i.e., 10% lower in patients admitted in the DXplain period (95% C I 1.2% , 18.2%,
P=0.006). Cost of service was $990 lower (P=0.001) per admission with intervention.
Statistically significant reductions in Medicare Part A charges were also reported. The
pre-implementation portion of the study was within one year in advance of the
intervention period, arguably reducing the impact of secular events biasing the findings.
The Clinical Evidence study, described earlier for its provider-level outcomes,
also measured length of stay [28]. There was no difference in length of hospital stay
between groups in that study.
We did not identify additional research articles evaluating an effect of CETs on
patient-level outcomes meeting the definition of this review. A systematic review [12] to
identify of randomized trials to increase the use of electronic health information by health
care practitioners to improve clinical practice and patient outcomes overlapped with
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CETs studies as defined here. It found no randomized controlled trials with a positive
effect of Health Information Technology on patient outcomes. That review was
concerned with electronic health information in general and on various devices. It
identified trials comparing information sources, including some CETs, for effectiveness
relevant to health care.
In this review, 12 randomized controlled trials or quasi-experimental research
studies directly evaluated an effect of CET(s) on provider practice or patient-level
outcomes. Of these, eight had a positive result for CET impact, three made no difference
on impact, and one had a significant negative effect. (See Table 1.4)

1.6 Discussion
This review identified research evaluating the impact of clinical evidence
technologies on provider practice and patient outcomes. Impacts on provider practice and
patients were measured on four CET types in 22 studies using multiple study designs
with provider-reported and independent data. In the discussion we synthesize the study
results on comparable outcomes to evaluate the strength of evidence we have reviewed.
1.6.1 Evidence of Provider Practice Impact with CET Use
There is some evidence of improved patient care with CET use in the providerreported outcomes studies and in the independent-measures studies. All of the providerreported data studies indicated perceived improvements in patient care with the
individual or multiple CETs evaluated. With independent verification of provider practice
improvement, the results were mixed.
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Patient Care Decisions and Time
Overall effectiveness of a CET for impact on patient care decisions and
physician time saved was measured in three RCTs in which intervention and control
groups were assigned, and participating PCPs evaluated results per question. All three
studies found statistically significant positive rating for patient care impact reported in
intervention assigned queries compared to the control queries (Alper, McGowan, and
Mulvaney)
In terms of provider time saved, a practice improvement that could increase
clinician productivity, the average time for the librarian search to answer the question
was 13.7 min per question compared to 20.3 minutes with provider search in the
McGowan study. In the DynaMed study, there was no difference in time providers spent
searching with and without DynaMed. These RCTs employed randomization and
provider report per question enhancing the validity of the clinician-report with immediate
response rather than longer term recall. These studies were positive for improved practice
outcomes but mixed on the provider time saved. Depending on institutional goals and
funding, evidence searches by a librarian intermediary for complex patient cases may
save provider time and produce better results.
Diagnosis, Treatments, Tests, and Referrals
The cross-sectional surveys of hospital clinicians by Marshall and Sievert
provided a detailed look at the provider perceived practice improvements [15, 16]. A
positive impact of CETs on diagnosis was reported by 25% and 71% of clinicians, on
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patient care management by 75% and 88%, on tests ordered by 19% and 78% in Marshall
and Sievert respectively.
In accord with the provider survey perceptions on those impacts, there were
positive findings for diagnostic accuracy, treatments and tests ordered found in three
studies with independent measures. Greater diagnostic accuracy was demonstrated with
the clinical topic summary UpToDate [32]. Fewer antibiotics were prescribed for
bronchiolitis with the CPOE-imbedded CET DXplain [28], and more evidence-based
therapies were prescribed after education in evidence retrieval and CET use (Strauss)
[22].
On the other hand, there was no difference in for evidence-based treatments and
tests after another CET education intervention [23]. Likewise there was no significant
difference in frequency of inpatient dermatology consults with the interactive diagnosis
CET, VisualDx [33], and no difference in general practitioners’ referrals to
dermatologists after introduction of a dermatology reference tool kit [31].
1.6.2 Evidence of CET Impact on Patient-Level Outcomes
In the studies measuring the effect of CETs on patient-level outcomes, there
were positive outcomes in two observational studies and one quasi-experimental study
and “no difference” or worse findings in an RCT and two quasi-experimental comparison
studies. Patient-level outcomes measured in these studies were: length of stay in hospital
(LOS), mortality or transfer to ICU, hospital readmission, and costs and charges for care.
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Length of Stay
Six of the 7 studies with patient-level outcomes measured length of hospital stay
(LOS). Of those, three found an improvement i.e. reduced length of stay for patients, and
three resulted in no difference or worse outcomes. The two observational studies of the
clinical topic summary UpToDate found reduced LOS equal to one-tenth to nearly twotenths of a day associated with hospitals that licensed the CET [29, 30]. The Banks casecontrol trial found a reduction in LOS by a median of 2.0 days (P=0.023) associated with
a librarian intermediary search.
Five other studies found no difference or worse LOS outcomes with the CET
intervention. In the RCT on handling difficult patient questions with an informatics
expert intermediary search, there was a non-significant half-day increase in LOS in the
intervention patients [20]. In the Clinical Evidence study average LOS increased nonsignificantly from 2.8 to 2.9 days with the intervention [28]. In the Esparza study, LOS
increased significantly in the intervention group by two days [21].
Mortality
Of three studies that evaluated a CET with a mortality outcome, only one
observational study found an association with decreased mortality (Isaac), the others
(Bonis and Izcovich) did not.
Costs, Charges and Readmission
One study found a significant reduction of total charges and service costs
associated with use of the DXplain, the interactive decision support CET. In the Esparza
study, there was no reduction of costs, or 30-day readmission in the intervention patients.
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1.6.3 Strengths and Limitations of the Review
This review included relevant studies that met inclusion requirements regardless
of study design, even if they were flawed in some way. One flawed study design
(Esparza) kept cases requiring a librarian search in the intervention group, while
transferring cases not requiring a search to the control team. This method of group
assignment all but insured that comparatively sicker, and complex cases remained in the
intervention group, making the significantly negative result improbable. The positive
result of two days reduction in LOS in the Banks study was flawed because of the 1-5
year difference between in observations between the intervention cases vs. controls. For
the LOS outcome, only the observational study of UpToDate retains a plausible
association with the CET evaluated. While the two large observational studies of
UpToDate made adjustments for differences between hospitals and patients, neither
adjusted for the availability of other CETs or evidence sources that may have been
present. That there were greater effect sizes in community hospitals than in the larger
teaching hospitals in the Isaac study could be due to the greater array of CETs usually
available in large settings.
In the Shimizu study on diagnostic accuracy with UpToDate, the lack of
description concerning the recruitment of physician participants, how case selection was
accomplished , and the blinding of the review panel are concerning. These omissions in
procedures raise questions concerning bias and validity in that study.
The CETs evaluated in this study were subject to change, making it difficult to
generalize about their individual value. Specific CETs and services in every category
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have changed or ceased to exist since the original research was published. This fact limits
any generalization about a particular CET.
A limitation of this review is that it may not include all relevant articles due to
variations in search terms for evidence technologies and patient outcomes, and due to the
iterative nature of the searches.
1.6.4 Implications
How might patient care be affected with use of high quality CETs? Elkin
suggested that the mechanism of improved patient outcomes and reduced costs may be
that use of the CET may broadens the differential diagnosis on first admission so that the
determination of the correct diagnosis occurs sooner. A similar argument was put forth by
David. It is possible that by following the behavioral steps of the evidence-based
medicine model in practice, from asking clinical questions, through acquiring evidence,
and applying evidence to patients, providers may improve provider practice and patientlevel outcomes [44, 45], but the evidence for that is limited based on the literature.
Future research is warranted. The provider-reported experience with CETs and
the positive outcomes of a few controlled and observational studies indicate that effects
of CET use might be demonstrated in randomized hypothesis testing research. Study
designs and outcome measurements would need to be carefully chosen to avoid errors
that bias the study or mask true effects.
1.7 Conclusion:
There is mixed evidence supporting an association of CET use with improved
provider and patient outcomes. Additional research with rigorous study designs, such as
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randomized trials, and appropriate patient-level outcome measures may further elucidate
impacts of CETs on patient care outcomes, particularly in clinically targeted area.
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1.8 Tables

Table 1.1: Studies on CET impacts with provider reported data
Author and
publication date

Study design/methods

Data source(s)

Participants/Sample

Setting

CET(s) evaluated: Name (if
any)

Outcomes Measured

Findings

Aitken, 2011

Cross-over design;
Residents rotated
through intervention and
control teams

Post-intervention provider
surveys; 6 month period.

50 Internal medicine
residents.

Teaching
hospital,
Canada

Multiple evidence sources;
intermediary librarian search
and brief instruction.

% Treatment decision
change

88% changed treatment
with skills learned and
74% changed treatment
plan with mediated
search.
44% changed diagnosis
with skills, and 36%
with librarian search.

% Diagnosis decision
change;
Alper, 2005
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Randomized Controlled
trial; Clinical question
by provider randomized
per question to
DynaMed vs. usual
sources

Clinician survey per question
asked

52 Primary care
providers; 698
clinical questions

U.S. + 3
hospitals in 3
other countries

Single CET; DynaMed

Questions answered that
changed clinical decisions
per participant

Duration of search

54% of PCPs found
answers that changed
clinical decisions with
DynaMed vs. 23%
without DynaMed, and
17% no decision
difference P=0.05
Median search time 4.8
min. vs. 4.9 min.
P=0.64.
35% of sessions in
control group reported
decision enhancement
vs. 18 (38%) in topic
enhanced group. 41
(36%): no difference

Del Fiol, 2008

Controlled trial;
comparative technology
assessment; computer
logs and survey

Computer log sessions
recorded, and questionnaire
presented immediately postsession

90 Clinicians in
matched pairs; 3,729
sessions

U.S.

2 CETs; Micromedex versions
in CPOE system Infobutton
prompted

Impact on decision- links to
evidence by topics
compared to links to named
evidence sources

Grad, 2005

Comparative technology
assessment; Impact of 2
clinical information
retrieval technologies;

Providers surveyed per search
session for impact of results;

26 Family Medicine
residents;4946
searches

Canada

2 CETs; CDSS with prediction
rules and calculators vs CIRT,
a CET with bibliographic
database and topic summaries.

Impact of each information
item retrieved from each
technology

CDSS associated with
practice improvement
more 25% vs 12% CIRT

Magrabi, 2004

Post-trial of CET
survey; Oct.-Nov. 2002

Computer log of usage per
participant; participant survey
based on recalled incident
during trial.

227 general
practitioners;
volunteers from
across Australia

Australia

Single CET; Quick Clinical
(QC), aggregated evidence
sources optimized for clinical
queries

Experience of
improvement in care.

25.6% (40) reported
experience of QC
resulting in improved
patient care after using
CET. With 6 or more
uses, 50% reported
improvement

Table 1.1 continued
Author and
publication date

Study
design/methods

Data source(s)

Participants/Sample

Setting

CET(s) evaluated: Name (if
any)

Outcomes Measured

Marshall, 2013

Cross-sectional
multi-site
critical incident
survey

Survey responses

16,122 Physicians,
nurses, and other
healthcare providers;
118 hospitals served by
56 medical libraries

U.S.

Multiple CETs provided by
medical libraries

Impact on:
Patient care

Prospective
cohort study;
Comparative
effectiveness of
2 drug
information
technologies;
randomized
Randomized,
controlled
study;
randomized per
question

Primary care providers
survey

359 providers; 18
outpatient clinics

U.S.

2 CETs; Micromedex
compared to Skolar MD

Patient advice
Diagnosis
Drug choice
Additional tests
Medication errors
Alteration of patient care
decisions

Search log and
provider questionnaire:
survey

88 Primary care
clinicians, 1889
questions

Canada

Multiple CETs with rapid
librarian search service: Justin-Time service

Maviglia, 2006
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McGowan, 2008

Mulvaney, 2008

Sievert, 2013

Randomized
controlled trial;
Clinician
consult request
assigned to
consult service
or no consult
service
Cross-sectional,
multi-site
survey

Post-consult request
CLIC search clinician
report and clinician
self-search report.

299 consults; 89
clinicians from 4
inpatient services

Academic
Medical
Center, U.S.

Multiple CETs with librarian
search service: Clinical
Informatics Consult Service
(CICS)

328 hospital providers
and caregivers in 4
hospitals including 203
physicians

4 hospitals 2
states, US

Multiple CETs;
PubMed/Medline; MDConsult
(electronic textbooks and
journals) plus other Library
provided sources

75% definitely or probably handled
patient care differently;
48% changed advice to patient
25% diagnosis change
23% drug choice
19% additional tests
12% medication errors avoided
No difference in decision changes
between groups; the 2 sources
combined resulted in patient care
decision change in 15% of searches.

Impact of search results on
clinical decision

20% of questions to librarian search
had a high positive impact on care
decisions vs. 5% of physician selfsearched questions

Librarian search time
compared to physician selfsearch time

Avg. librarian search 13.7 min (95%
CI 13.3, 13.8) per question vs. 20.29
min. (CI 18.7, 21.86) with provider
search
Different or new treatment 14.9%
with CICs consult vs. 4.8% no CICS
OR 8.2 (95%CI 1.04 -64.0).

Actual impact on care;

Specific impacts on
clinician actions regarding
diagnoses and treatments
Survey; recall in any
incident.

Findings

No difference in diagnosis related
actions

Library CETs:
Management impact
Decision confirmation
Advice to patient

88% changed management of patient
84% of physicians confirmed
decision
84%; changed advice to patient

Table 1.2: Studies on impact of CETs on provider practice outcomes
Study design/methods

Data source(s)

Participants /Sample

Setting

CET Source(s) Type:
name (if any)

Outcomes Measured

Findings

Barbieri, 2015

Interrupted time series; 12
months before and 18
months after VisualDx
implementation

Patient records;
dermatology
consults requested

System-wide physicians
and patients

Academic Health
care system; US

Single CET: VisualDx

Absolute number of
consults

Absolute number of consults
decreased by median 4.6, nonsignificantly P=0.75

Rate of increase in
consults before v. rate of
increase of consults after

Consults increased at a rate of 1
consult per month in both periods
P=0.99

David, 2011

Comparison of correct
diagnoses in differential
by physicians with
VisualDx vs admitting ED
physicians without it;

Patient admission
records; postadmission review

145 patients diagnosed
with cellulitis in ED;
Comparison on 28
misdiagnosed cases

2 teaching
hospitals; U.S.
California and
New York

Single CET: VisualDx

Inclusion of the correct
diagnosis in the
differential diagnosis in
misdiagnosed cases

Gulati, 2015

Observational;
Comparison of national
skin cancer referrals pre
and post CET.
Cross-sectional survey
post-deployment of toolkit

Health service
referral database

General practitioners;
20% of General
practitioners in England
accessed the toolkit in 6
month period 2012

England

Single CET: Skin cancer
educational toolkit

Number of skin cancer
referrals

Correct diagnosis was included in
differential with VisualDx (18/28
64%) vs. the admitting team
without Visual Dx had the correct
diagnosis in 4/28 cases (14%)
P=0.003
No difference in referrals behavior
in national database pre vs. posttoolkit year

Before and after evidence
module implemented

Hospital
pharmacy and
discharge records

334 Pediatric inpatients
with bronchiolitis
diagnosis 147 pre- 187
post year following
intervention; resident
physicians and medical
student trainees
100 outpatients of GPs
with and without
UpToDate; "equipped vs.
"non-equipped" GPs

Pediatric hospital,
Ottawa Canada

Ambulatory
clinics of teaching
hospital Tokyo,
Japan

Single CET: UpToDate

Diagnostic errors per
group

2%diagnostic error rate in exposure
to UpToDate group vs 24% error
rate in control. OR 15.2 (95% CI
1.86, 124.4)

Primary care clinics; 75
PCPs and 106,349 patient
records

HMO clinics;
Israel

Education in EBM
evidence retrieval and
appraisal methods

% adherence to evidence
for tests ordered

No statistical difference in
evidence-based tests ordered such
as eye examination (P=0.67)

% adherence to evidence
for drug utilization

Patient drug utilization such as for
statins (P=0.87) after intervention

Treatments ordered in line
with available RCT or
systematic review
evidence

Proportion of treatments supported
by RCT or systematic review
increased from pre- 49% to postintervention 62% (P=0.016)
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Author and
publication date

King, 2007

Survey

Shimizu, 2017

Retrospective chart
review comparison;
"patients randomly
selected"

Patient records;
initial diagnoses

Shuval, 2007

Controlled trial; Pre-Post
evaluation of education;

HMO patient
database for
controlled trial;

Straus, 2005

Pre-Post-intervention
chart review of discharge
summaries

Patient discharge
summaries

47 physicians; 239
patients pre-, 244 post

Improved confidence in diagnosis

Single CET: Clinical
Evidence Module

% frequency of antibiotics
prescribed
Bronchodilators and
steroids prescribed

Single site
teaching hospital,
UK

Education in EBM
evidence retrieval and
appraisal methods

Fewer antibiotics prescribed; 35%
to 22%, relative decrease 37% P=
0.016
No difference in bronchodilators
and steroids

Table 1.3: Studies on impacts of CETs on patient-level outcomes
Author and
publication
date

Study design/methods

Data source(s)

Participants/sample

Setting

CET Evaluated
/Name(if any)

Outcomes
Measured

Findings

Banks, 2007

Case-control; prospective
cases, retrospective controls

Patient records

55 prospective inpatient cases
to 136 matched retrospective
controls seen by Medicine
residents

US, academic
medical center

Multiple CETs with
intermediary search and
filter by clinical medical
librarian.

Length of stay
(LOS) (days)

LOS reduced 2 days (P=0.023)

Charges for
hospitalization

Total charges lower, median $1,392,
non-significantly P=0.24

30-day
readmissions
LOS (days)

No difference in readmission rate

Complications
Patient safety
indicators (AHRQ)

Complications -0.378 P=0.048
Patient safety -0.08 P<0.001

Bonis, 2008
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Observational study;
Hospitals with and without
CET compared; adjustment
for size, region, and level of
usage of the system

Thompson Top
100 Hospitals
Study
database;
Publisher
licensee
identification.

Medicare beneficiary
inpatients at 3091 U.S.
hospitals; 424 hospitals with
UpToDate

US

Mortality

Mortality 0.179 P=0.34

Elkin, 2010

Before and after
implementation of evidence
support tool; Residents used
DXplain; Pt cases identified
in DRG groups (all
Medicare)

Patient records

Residents; Diagnostically
challenging patients:1173 preperiod; 564 post- period

Teaching
hospital, Mayo
Clinic,
Rochester Minn.

Single CET/DXplain

Total charges and
cost of service for
diagnostically
challenging patients

Total charges $1281 lower P=0.006.
Medicare Part A charges $1032 lower
P=.006; Cost of service $990 lower
P=0.001 per admission in intervention
(DXplain cases vs. control cases

Esparza, 2013

Prospective matched cases.
Data collection 78 weeks
2008-9

Patient records

2 physician teams; internal
Medline service patients. 252
cases, 1948 controls

Urban Academic
Medical Center
US

Multiple CETs with
intermediary search and
filter by clinical medical
librarian

LOS (days)

LOS, higher median 6 vs. 4 P<0.001

% 30-day
readmission

Readmission rates higher 19% vs. 13%,
P<0.001

Observational study;
Retrospective comparison
of hospitals with vs.
without CET.

CMS Medicare
data for US
hospitals;
publisher
supplied
license status.
Patient records

Fee-for-service Medicare
beneficiaries. 3000 US
hospitals; Medicare patients

US

Single CET/UpToDate

Risk-adjusted LOS
(days)

LOS 5.6 vs. 5.7 days P=0.001 (CI -0.2,
0.00)

Mortality rates for 3
conditions

Mortality range -0.1% - 0.6% reduction

809 patients admitted to
Medicine ward

Academic
medical center,
Argentina

Multiple CETs with
intermediary search and
filter by informatics
specialist.

LOS (days)
Mortality or
transfer to ICU,
Readmission

LOS 6.5 v 6 days,
Mortality or ICU transfer RR 1.09 (95%
CI 0.7, 1.6)
Readmission RR 1.0 (95%CI 0.7, 1.3)

Patient records

334 pediatric inpatients with
bronchiolitis diagnosis; 147
pre-, 187 postimplementation.

Pediatric
hospital, Canada

Clinical Evidence
Module (BMJ Clinical
Evidence) integrated
with CPOE

LOS (days)

Median LOS increased 0.1 day post
implementation P=0.125 ER through
admission and discharge

Isaac, 2012

Izcovich, 2011

King, 2007

RCT; patients randomly
assigned to literature search
support for provider
questions vs. no support.
Intention-to- treat analysis
Before and after evidence
module implemented

Single CET/UpToDate

LOS reduced 0.167 days (P<0.001)

Table 1.4: Twelve randomized controlled trials or quasi-experimental studies that evaluated an
effect of CET interventions on provider practice or patient-level outcomes
First author,
year published

Study design;
sample size

CET type and/or
name

Outcome(s)
measured

Alper, 2005

RCT; 52 PCPs, 698
queries
Case control; 55
inpatient cases to 136
controls

DynaMed

% changed clinical
decisions
LOS (days)

Banks, 2007

Barbieri, 2015

Elkin, 2010

Esparza, 2013

Izcovich, 2011

King, 2007

Interrupted time
series; system-wide
patients
Before and after;
1173 patients pre-,
564 post-intervention

Multiple/Intermediary
evidence search

Hospital charges

VisualDx

Change per month in
skin consults

DXplain

Total charges/pt.

Multiple/Intermediary
evidence search

RCT; 809 patients

Multiple/Intermediary
search

Clinical Evidence

LOS (days)

(+) $990 lower
P=0.001
(-) 6 vs. 4 P<0.001

%Readmission to
hospital
LOS (days)

(-) 19% v. 13%,
P<0.001,
(-) 6.5 vs.6 P=0.25

Mortality or ICU

(-) RR 1.09 (95%CI
0.7,1.6)
(+) 22% vs. 35%, P=
0.016

% antibiotics
prescribed
LOS (days)

McGowan,
2008

RCT; 88 PCPs, 1889
queries

Multiple/Intermediary
search: JIT

Mulvaney, 2008

RCT; 89 physicians;
299 consults

Multiple/Intermediary
search: CICS

% queries with
impact on care
decisions
% different or new
treatment

Shimizu, 2017

Parallel “with and
without”; 100
patients
Controlled trial; 75
PCPs, 106,000
patients

UpToDate

% diagnostic errors

Education in EBM
methods

% adherence to
evidence for tests

Before and after; 47
physicians, 483
patients

Education in EBM
methods

% adherence to
evidence for
treatment

Shuval, 2007

Straus, 2005

(-) $1,392 lower
P=0.24,
(-) 1 consult/mo.
increase vs. same
P=0.99
(+) $1281 lower
P=0.006.

Cost of service/pt.

Prospective casecontrol; 252 cases,
1948 controls

Before and after; 334
inpatients

Effect (intervention
v. control) or
difference (+ =
significant result)
(+) 54% vs. 23%
P=0.05
(+) 2 days lower
(P=0.023);
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(-) Increased 0.1 day
P=0.125
(+) 20% vs. 5% P=NA

(+) 14.9% vs. 4.8%
OR 8.2 (95% CI 1.04,
64.0).
(+) 2% vs. 24% OR
15.2 (95% CI 1.86,
124.4)
(-) no difference,
P=0.67,
(+) 62% vs. 49%
(P=0.016)
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Effect of a Clinical Evidence Technology on Patient Skin Disease
Outcomes in Primary Care: A Cluster-Randomized Controlled Trial

2.1 Abstract
Objective: Providers’ use of clinical evidence technologies (CETs) improves their
diagnosis and treatment decisions. Despite these benefits, few studies have evaluated the
impact of CETs on patient outcomes. Investigators evaluated the effect of one CET,
VisualDx, on skin problem outcomes in primary care.
Methods: A cluster-randomized controlled pragmatic trial was conducted in outpatient
clinics at an academic medical center in the Northeast. Participants were primary care
providers (PCPs) and their adult patients seen for skin problems. The intervention was
VisualDx as used by PCPs. Outcomes were patient-reported time from index clinic visit
to problem resolution, and the number of follow-up visits to any provider for the same
problem. PCPs randomly assigned to the intervention agreed to use VisualDx as their
primary evidence source for skin problems. Control group PCPs agreed not to use
VisualDx. Investigators collected outcome data from patients by phone at 30 day
intervals. Cox proportional hazards models assessed time to resolution. Wilcoxon-rank
sum tests and logistic regression compared need for return appointments.
Results: Thirty-two PCPs and 433 patients participated. In proportional hazards
modelling adjusted for provider clusters, the time from index visit to skin problem
resolution was similar in both groups (Hazard Ratio=0.92; 95% Confidence Interval
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(CI)=0.70, 1.21; P=0.54). Patient follow-up appointments did not differ significantly
between groups (Odds Ratio=1.26; CI=0.94, 1.70; P=0.29).
Conclusion: This pragmatic trial tested the effectiveness of VisualDx on patient-reported
skin disease outcomes in a generalizable clinical setting. There was no difference in skin
problem resolution or number of follow-up visits when PCPs used VisualDx.
2.2 Introduction
Health care providers across a spectrum of primary care and specialty domains
regularly refer to clinical evidence technologies (CETs) to answer clinical questions [1].
As reported in provider survey and chart review studies, use of CETs such as
PubMed/MEDLINE, journal articles, electronic texts, topic summaries, and internet
search engines has improved diagnosis and treatment decisions and avoided adverse
events [2-6]. Despite these provider reports, few studies have evaluated the impact of
CETs on patient-level outcomes. Patient-level outcomes include mortality, relief of
symptoms, impact on activity, perceived benefit, and costs to the patient such as length of
hospital stay and lost work time [7]. The literature on patient outcomes of CET use is
mixed. Only one published study has reported an improvement in patient outcomes.
Researchers reviewed insurance claims from hospitals before and after subscribing to
UpToDate (a source for comprehensive medical topic summaries). Results showed a
modest reduction in morbidity and length of stay in hospitals after subscribing [8].
Hospital libraries and informatics centers acquire and make CETs available to
the clinical community on the assumption that these resources have value for education,
practice improvement, and the outcomes of care. CET licenses can be expensive. Medical
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school libraries associated with teaching hospitals in the US or Canada spent an average
of $US 2 million each in 2015 for medical research journals and clinical information
resources [9].While CETs, individually or in combination, have been evaluated for
education and practice-level outcomes, they have not undergone the rigorous evaluations
with randomized trials for patient outcomes. A 2015 systematic review of electronic
health information (EHI), including CETs, found no randomized trials with patient
outcomes, such as relief from symptoms or utilization [10].
The broad nature and diverse goals of many CETs may discourage rigorous
evaluation. However, skin conditions are a relatively circumscribed domain within the
broad field of Primary Care. The clinical goal in many cases can be quantified as time to
problem resolution. Likewise, the need for additional medical care after the index visit
usually represents a suboptimal and expensive outcome that might be reduced by
improved provider knowledge and decision support [11].
Skin problems account for 15% of primary care office visits in the U.S [12] and
ten common dermatologic conditions (dermatitis, pyoderma, tinea, benign neoplasms,
candida, dermatosis, warts, malignant neoplasm, sebaceous cyst, and acne) account for
77% of skin-related diagnoses in Family Practice. Likewise, many internal conditions
manifest themselves on the skin, including malignancies, vascular conditions, anemia,
endocrine disorders and pregnancy. Most skin conditions first present, and are often
diagnosed and managed, in primary care. Eight percent of all outpatient visits for skin
problems result in referrals to dermatologists or return visits to primary care [13].
Limitations in the ability of primary care providers (PCPs) to diagnose skin rashes and
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lesions correctly have been noted in the literature [14, 15]. Some studies have indicated
that additional dermatology knowledge, training, and diagnostic support could improve
practice and patient outcomes. General Practitioners in the UK who used an online skin
cancer diagnosis information source increased their diagnostic accuracy and confidence,
but did not reduce referrals [16]. Referrals to Dermatology in a VA hospital that lacked a
specific diagnosis were reduced by an intervention that trained PCPs. [17]
VisualDx is a CET that presents images and text on a comprehensive range of
skin conditions and symptoms whether they are local to the skin or are manifestations of
internal conditions [18]. Users may search by diagnosis or by entering patient
characteristics and examination findings to generate a differential diagnosis list with
images. Individuals, practices, and institutions license VisualDx to support medical
education and patient care [19]. VisualDx has been shown to improve diagnostic
competency in non-primary care settings. In one study, its use improved the differential
diagnosis of cellulitis by Emergency Room physicians [20]. In a pilot study, diagnostic
accuracy of dermatology residents and medical students increased after using VisualDx
as judged by a consultant dermatologist [21].
Given the prevalence and broad range of skin conditions seen in Primary Care,
the need for improved knowledge and competency by PCPs in skin disease, the
availability of a dermatology-focused CET (VisualDx) shown to affect clinical
competence, and the lack of randomized clinical trials of any CET with patient-level
outcomes, we proposed a clinical trial to evaluate use of VisualDx in Primary Care in the
domain of skin disease with patient-level outcomes.
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Our objective was to evaluate the effect of VisualDx on duration of symptoms
and follow-up care for skin problems in a pragmatic randomized clinical trial in primary
care. Recognizing that in typical clinical care, the correct diagnosis and therapy are often
uncertain, that some problems resolve regardless of whether the management was
technically correct, and that some resist even the most insightful management, we were
concerned in this study with the net result of each episode of care – the patient outcomes
– rather than the intermediate steps of management, i.e. diagnosis or treatment decisions.
2.3 Methods
2.3.1 Study Design, Model, and Setting
We designed a cluster-randomized controlled trial (CRCT) to evaluate the
outcomes of skin problems in patients whose PCP referred to VisualDx or not (usual
care). In this design, PCPs were the subjects of randomization. Patients were clustered
within the arm of the provider they saw for the skin problem. The cluster design was
appropriate because the intervention is directed to physicians while the outcomes occur
within individual patients [22]. With randomization, environmental and provider or
subject characteristics (such as years in practice, insurance status, chronicity of the
presenting complaint, comorbidities, etc.) are distributed at chance levels across both
arms of the experiment. The model underlying the design of the experiment asserts that
the CET supports the PCP in management (diagnosis, treatment, and referral decisions)
and impacts patient-level outcomes, resolution of symptoms and return appointments,
when used in a real-world clinical setting. Presumably, use of a valuable CET leads to
more correct diagnoses and wiser therapeutic or referral choices. These, in turn, lead to
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better patient outcomes (quicker resolution of the presenting problem or reduced need for
additional care). To test this model, we performed a pragmatic [23], (i.e. not heavily
controlled), cluster-randomized controlled trial of the impact of one CET on the
outcomes of skin problems presenting to Primary Care
The study was conducted at clinics associated with an academic regional
medical center in the Northeast. VisualDx and other CETs were available to medical

Figure 2.1: Model of the cluster-randomized pragmatic design

center clinicians through the hospital Intranet, electronic health record (EHR), and mobile
devices. The Institutional Review Board approved the protocol in June 2015.
2.3.2 Provider Subjects
Attending physicians, residents, advanced practice nurses, and physician
assistants in outpatient Family Medicine and General Internal Medicine were invited to
participate by email or personal contact. Eligible providers 1) were currently seeing
patients at a Primary Care site, 2) consented and agreed to comply with the protocol
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procedures assigned, and, 3) permitted patients to be informed of the study via a letter
sent over their signature. Providers answered a survey concerning resident/attending
status, year of clinical degree, sex, specialty, and typical number of times per month they
used CETs for patient care. (See Appendix I)
We randomly assigned PCPs to intervention or control groups using a sequential
numbered envelope method stratified by resident status [24]. We randomized residents
independently because of the possibility that they respond differently to the intervention
than more experienced providers. PCPs were enrolled in the study when they gave
consent, completed the tutorial, provided their signature for patient letters, and reaffirmed
their agreement to follow their assigned protocol.
2.3.3 Patient Subjects
Adult patients seen for acute or chronic skin problems, excluding lacerations or
burns, were eligible. Patients were excluded if non-English speaking or decisionally
impaired. To identify patients, investigators reviewed the appointment records of
participating providers for patients seen for a skin problem. We identified patients with
any complaint in the broad range of skin disease as noted in the EHR. The Reason for
visit, Appointment note, and Clinical summary fields provided patient complaint
information such as “rash”, “redness”, “lump”, “itch”, “wart”, “mole”, or “sore”. ICD
codes were also used to identify potential cases. Per the institutionally-approved protocol,
personal health information from the patient record such as reason for visit, phone
number, and address could be used for identification and recruitment but not to ascertain
patient characteristics or outcomes.
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We sent each identified patient a letter signed by their PCP describing the study
and informing them that the study team would call to invite their participation. The letter
also stated how to opt out of any contact.
2.3.4 Intervention
The intervention was VisualDx as used by PCPs treating patients with skin
problems. Providers received email notification of their experimental group status with a
link to a self-paced slide tutorial specific to their group. (See Appendix II and III) For
the Active group, the 5-10-minute tutorial included the direction to use VisualDx when
needed in treating a patient skin problem, and how to access and use it. For Control
providers, the tutorial included the direction not to use VisualDx, and a general
orientation to information sources available through the Medical Library. A study team
member contacted participating providers by email, phone, and letter at intervals during
the study to remind them of their assigned protocol, and to re-confirm their continued
participation.
2.3.5 Measurements
The primary predictor (independent variable) was the randomized group status
of the provider: Active (use of VisualDx) or Control (non-use). Patient subjects were
assigned to the group of the provider they saw. The primary outcome variables reported
by the patients were: 1) time to resolution of the skin problem from presentation at the
primary care office visit and 2) number of follow up visits (to any provider) for the same
problem.
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About 30 days after the index visit, an investigator phoned each eligible patient
(except those who had opted out) and, following verbal consent, proceeded with the
interview questions. If the patient reported their presenting skin problem resolved, i.e.
“All better”, their participation in the study was concluded. Patients whose presenting
complaint had not resolved were re-interviewed at 60 days and, if still unresolved, again
at 90 days. The 30-60-90 day phone call schedule was specified in the protocol to
balance the requirements to reach many people while preserving patient recall [25].
At the first interview, patients reported their age, sex, and whether the PCP seen was
their usual provider (See Appendix IV).We ascertained the status of the skin problem as
“All better”, “Improved,” Unchanged”, or “Worse”, each time we interviewed the patient.
If “All better” at any interview, we asked them to recall the number of days from the
index visit date or the date when they realized the problem was resolved. If necessary, we
asked questions to aid more exact recall. This determined the “days to resolution”
outcome data. If the problem was not resolved by the first interview, we interviewed the
patients at 60 days, and if still not resolved, at 90 days. The final problem status at the
last completed interview was determined for analysis.
For the number of follow-up appointments, at the first interview, we asked how many
appointments the patient had for the same problem since the index visit. If there was a
second or third phone interview, we asked how many appointments they had since the
last call and added that number to any previously reported appointments, if any. The total
number of appointments reported comprised the variable.
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2.3.6 Data Collection
Trained research assistants using standardized scripts conducted patient
interviews by telephone. Study data were collected and managed using REDCap
(Research Electronic Data Capture) secure tools hosted by the researchers’ institution.
2.3.7 Blinding
By necessity, providers knew their own intervention or control group status.
Investigators were blind to providers’ and patients’ group while conducting patient
interviews. Patients were blind to the group assignment of their provider.
2.3.8 Analysis
We used Cox proportional hazards models to assess time to resolution and
Wilcoxon-rank sum tests and logistic regression to compare return appointments between
groups. Logistic and proportional hazards models were adjusted for clustering. Data
analyses were performed using Stata 14 statistical software [24]. We sought an adequate
sample size to detect a moderate-to-large effect of the intervention, on the order of 0.4
standard deviations. Given the broad range of skin problems presenting in Primary Care,
we expected significant variability in the time to resolution. Therefore, we chose a target
of 8 days in time to resolution with a standard deviation of 20 days. The effect of
clustering within PCP was not known, but we used estimates from other primary care
settings that suggested an intra-cluster correlation of approximately 0.025 [20]. Assuming
alpha=0.05, beta=0.80, 10 patients per provider, and a two-sided t-test, we estimated the
study needed 26 PCPs and 260 patients.
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2.4 Results
We enrolled 31 physicians and 1 nurse practitioner. We identified 989 eligible
patients with a skin problem visit to a participating PCP between November 2015 and
August 2016. 433 patients consented and provided data.

Figure 2.2: Flow of participants through stages of the cluster-randomized controlled trial

The active and control groups were similar at baseline except for the median number of
subjects per PCP (6 in the active group vs. 15 in the control group; P=0.045). Seven PCPs
(22%) reported use of VisualDx prior to the study including 4 (27%) in the Control group
who agreed not to use it during the trial.
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Table 2.1: Characteristics of primary care providers and patients
All
Active
Control
Primary Care Providers, n

P*

32

17

15

Residents

13 (41%)

8 (47%)

5 (33%)

0.43

Sex (male)
Family Medicine (vs. Internal
Medicine)
Year graduated, median
(range)

17 (53%)

10 (59%)

7 (47%)

0.49

14 (45%)

6 (35%)

8 (53%)

0.30

2010

2012

2002

0.44

(1976-2015)

(19762015)

(19772015)

13.5 (1-34)

6 (1-32)

15 (1-34)

0.045

27 (84%)

13 (77%)

14 (93%)

0.19

7 (22%)

3 (18%)

4 (27%)

0.54

Study patients per provider,
median (range)
Used any CET>10 times prior
month
Used VisualDx prior month
(yes)

Patients, n
433
158
275
Age in years, median (range),
58 (19-94)
58 (20-91) 58 (19-94)
0.73
431 obs.
Sex (male), 431 obs.
214 (49%)
77 (49%)
137 (50%)
0.54
Completed all protocol
360 (83%)
126 (80%) 234 (85%)
0.15
interviews
Unless noted, all cells contain n and (%). *P-value comparing Active and Control groups from
Χ2 tests for categorical variables (proportions) and Wilcoxon Rank-Sum tests for ordinal and
continuous variables.

2.4.1 Problem Resolution
48% of all patients in the study considered their skin problem resolved (“All
better”) by the final contact, including 46% in the active group and 49% in the control
group (P=0.48). Active and control patients were similar in terms of whether they were
“All better”, “Improved”, “Unchanged” or “Worse” at their final interview (P=0.88).
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Table 2.2: Problem resolution and return visit outcomes
All subjects
Active
Patients, n

433

158

Control
275

Final skin status

0.88

Resolved

207 (48%)

72 (46%)

135 (49%)

Improved

104 (24%)

41 (26%)

63 (23%)

Unchanged

108 (25%)

40 (25%)

68 (25%)

14 (3%)

5 (3%)

9 (3%)

Worse

P*

Return visits
Return visits per patient,
0.59 (1.07)
0.65 (1.10)
0.55 (1.05)
0.19
mean (standard deviation)
Any return visits (vs. none)
148 (34%)
59 (37%)
89 (32%)
0.29
2
Unless noted, all cells contain n and (%). *P-value comparing Active and Control groups from Χ tests
for categorical variables (proportions) and Wilcoxon Rank-Sum test for number of visits.

Time to resolution was similar in the two groups throughout the observation period of up
to 120 days (P=0.56 by log-rank test).

Figure 2.3: Proportion of patients whose skin problems remained unresolved over time
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In univariable Cox proportional hazards modelling, with standard errors adjusted
for provider clusters, the days from index visit to resolution were similar in both groups
(Hazard Ratio (HR)=0.92; 95% Confidence Interval (CI)=0.70, 1.21; P =0.54). Tests for
potential confounding by patient age and sex, PCP status (as resident and as patient’s
regular provider), PCP time since graduation, number of subjects per provider, and time
of the year, indicated no potential confounding. Therefore, these variables were not
included in the analysis.
2.4.2 Return Appointments
Active group patients had a mean of 0.65 return appointments compared to 0.55
in the control group (P=0.19). The median was 0 return appointments in both groups.

Figure 2.4: Return appointments for 433 skin patients by experimental group
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Thirty-seven percent of active patients had one or more follow-up appointments for the
index problem vs. 32 % of control, P=0.29.
When analyzed as a binary variable (any follow-up visits vs. none) in clusteradjusted logistic regression, the odds of a return visit in active group patients were higher
than in the control group (Odds Ratio (OR) =1.25; CI =0.93, 1.67; P=0.15) but were not
statistically significant. Tests for potential confounding by patient characteristics (age and
sex), PCP characteristics (as resident, as patient’s regular provider, and time since
graduation) or time of the year indicated no confounding. Therefore, these variables were
not included in the model. However, the number of patients per provider was associated
with both the use of any follow-up visits (P=0.066) and group assignment (P=.065)
raising the possibility of confounding and was included in the final logistic regression
model. The odds of any follow-up visits remained higher in the active group than the
control group when adjusting for clustering and the number of subjects per provider
(OR=1.14; CI=0.84, 1.56; P=0.39), but was not statistically significant. The intra-cluster
correlation coefficient for both outcome measures was <0.00001 with an upper 95%
confidence limit of 0.039.
2.5 Discussion
Patients with skin problems whose PCPs used the CET VisualDx experienced
similar rates of problem resolution and similar time to resolution as patients whose
providers did not use it. There was no difference in the number of follow-up visits to any
health-care provider for the index skin problem.
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The goal of this study was to assess effectiveness of a CET as used in a
generalizable clinical setting, rather than to determine its mechanism of action or efficacy
under ideal conditions. Therefore, we designed a “pragmatic trial” in a clinical
environment in which day-to-day factors were not highly controlled. Pragmatic trials seek
to answer the question “Does this intervention work under usual conditions?” [23].
Intervention PCPs had flexibility in how they followed their assigned protocol to
reference VisualDx when a patient care uncertainty arose. They could have searched
within VisualDx by diagnosis terms, as opposed to using the differential diagnosis
support tool. They could also decide that assistance was not needed with some patients
and opt not to employ the CET. They could seek advice from additional sources after
consulting VisualDx.
We obtained data for the primary outcomes from patient reports because we
sought to understand the outcomes of care as the patients experienced it. Patient-reported
outcome measures complement other health care indicators such as provider-reported
outcomes, chart review, and insurance data. They are appropriate measures in research
when the intervention is incorporated into treatment [26, 27]. They are frequently used in
clinical trials of medical products, drugs, and in health-related quality of life studies [28].
We did not evaluate whether the diagnosis or treatment decided upon by the PCP was
correct by an objective standard, such as expert dermatologist review. Likewise, we did
not distinguish appropriate follow-up appointments or referrals from unnecessary or
avoidable ones, recording only that a follow-up occurred.
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Physician-reported benefits of referring to CETs, such as correct diagnosis,
treatment, and avoidance of adverse events have been noted previously. Marshall et al. in
multi-institutional survey of physicians (n=4,906) and residents (n=1,290) in 118
hospitals, found that 36% of physicians and 42% of residents changed a diagnosis after
referring to a clinical evidence source in a recent recalled incident. Physicians (29%) and
residents (32%) also reported avoidance of unnecessary procedures or tests because of the
information they used in the incident [5].
Likewise, use of VisualDx may improve diagnostic skills. A team including the
developer of VisualDx reported that among 28 cases initially misdiagnosed as cellulitis in
the Emergency Room, VisualDx included the correct diagnosis in its differential
diagnosis list more often than the admitting medical resident (64% vs. 14%; P=0.003). In
a pilot study by Chou, clinical diagnoses of 13 patients were made by 13 dermatology
residents and 51 medical students before and after using VisualDx. Diagnostic accuracy
increased from 63% to 81% (P <0.01) as judged by a consultant dermatologist [23].
Despite these positive intermediate effects, the published literature, including the study
reported here, provides no evidence of better patient outcomes.
Why did use of VisualDx, a technologically sophisticated, well-designed, stateof-the-art CET, fail to influence the tested outcomes for skin disease? Some potential
reasons for the negative results in this trial, such as bias due to uneven distribution of
patient or provider characteristics, were minimized by the randomized design of the
study. Another reason we found no difference between groups could be that the VisualDx
users had insufficient knowledge of the resource to use it effectively. However, active
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group PCPs were made aware of the resource, what it was meant to do, and how to access
it. They received more training on its features, via an online tutorial, than is usually
available in clinical practice. Although the VisualDx interface appears intuitive and easy
to use compared to other CETs (PubMed/MEDLINE for example), it is possible that
PCPs found it difficult to find the information they needed. The specific content and
interactive diagnosis tool of VisualDx, written largely by specialists, could be too
complex or time-consuming in the Primary Care setting. This may have contributed to
busy clinicians bypassing VisualDx at times, resulting in suboptimal management.
Even if the content acquired by the PCPs was correct from a biomedical pointof-view, the PCPs were not obligated to follow it. Indeed, local availability of certain
procedures, prescriptions, and specialty referrals may make it unreasonable or impractical
to follow the advice of the CET, leading to the “no difference” result.
Finally, it is possible that many skin problems presenting in Primary Care are
inherently resistant to improvement no matter how well-managed. They will resolve (or
not) at their own pace regardless of the diagnosis and therapy offered. Nonetheless, one
supposes that return appointments and referrals to dermatology could be reduced with
optimal Primary Care management.
This study tested the effectiveness of VisualDx for problem resolution and
return visit frequency, not for other outcomes such as improved diagnosis, or satisfaction
with care. This was not a comprehensive multi-attribute assessment of the CET.
Likewise, ease of use and usefulness were also beyond the scope of this evaluation.
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VisualDx is costly, and this study may help health care organizations determine whether
that cost is appropriate for their local institutional goals and settings.
2.5.1 Strengths and Limitations
The cluster-randomized parallel design reduced the likelihood of bias due to
differences in the provider and patient subjects. Secular events occurring outside the
study, such as seasonal changes in skin-related appointments, affected providers and
patients in the intervention and control groups equally because of the randomized,
parallel design.
The study took place in one large academic medical center, possibly reducing
generalizability to other settings. However, the patients of the study institution are similar
to populations in rural regions of the United States in terms of age, race, poverty rates and
other factors.
Although this is the largest randomized study of a CET with patient outcomes to
date, the power to detect a potential effect was limited. Given the sample size of 433
patients, a control resolution rate of 49% within 90 days, and assuming α=0.05, the study
had 80% power to detect a resolution rate of at least 63% in the active group using Chisquare analysis. The observed rate was 46% and therefore not significantly different from
control. In the Cox model, the observed Hazard Ratio of 0.92 (favoring control) was well
under the minimum detectable HR of 1.24. Likewise, the study had 80% power to detect
a difference of 0.30 return visits per patient. The observed rate was 0.10 higher in the
Active group. Given that all analyses showed a trend towards worse outcomes, i.e. longer
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time to resolution and more return visits in the Active Group, it highly unlikely that a
larger study would have demonstrated a statistically significant beneficial effect.
The study relied on provider adherence to the protocol based on their agreement to do so
(which was confirmed periodically). We did not have independent confirmation of their
adherence. There may also have been contamination between provider subjects since
there were both active and control providers in some clinics. While the active group PCPs
used VisualDx as their primary resource for skin-related uncertainty and the control
group did not, both groups could use other CETs and resources available in the
information-rich environment of the academic medical center. This access could have
masked a positive effect of using VisualDx.
We had limited ability to independently measure participant usage of VisualDx prior
to the study. However, at baseline, 22% of PCPs reported use of VisualDx in a prior

month with no significant difference between groups. We did not measure VisualDx use
during the study. Nevertheless, we did encourage provider adherence to the protocol.

When contacted, all providers confirmed they were staying within their assigned
protocol, to use VisualDx as a reference or not.
The study relied upon the memory of patients which could have been faulty.
However, the first patient interviews followed the index visit by approximately thirty
days, a relatively short time span [25]. Only one patient who consented could not
remember the skin problem visit at all.
This study included patients with acute and chronic conditions reflecting the
usual variety of skin conditions seen in primary care. It is possible that a study of only
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acute skin conditions, or a study in an inpatient setting, might have had a different
outcome.
2.5.2 Implications
While this CET did not make a difference in the patient outcomes studied, it
may have value for other goals such as medical knowledge, decision confirmation, and
diagnostic confidence. The pragmatic study design with patient-level outcomes proved to
be feasible, and could be extended to evaluate other clinical evidence source technologies
relevant to health care.
2.6 Conclusion
The study showed no difference in resolution of symptoms and return visits in
patients of doctors who referenced VisualDx. Although VisualDx and other CETs may
support institutional missions of medical knowledge and practice improvement, VisualDx
does not appear to improve patient outcomes for skin problems managed in Primary Care.
2.7 References
1. Ely JW, Osheroff JA, Chambliss ML, Ebell MH, Rosenbaum ME. Answering
physicians' clinical questions: obstacles and potential solutions. J Am Med Inform Assoc.
2005 Mar-Apr;12(2):217-24. DOI: http://dx.doi.org/ 10.1197/jamia.M1608
2. Alper BS WD, Ge B. Physicians answer more clinical questions and change clinical
decisions more often with synthesized evidence. Ann Fam Med. 2005;3(6):507-13. DOI:
http://dx.doi.org/ 10.1370/afm.370.
3. Del Fiol G, Haug PJ, Cimino JJ, Narus SP, Norlin C, Mitchell JA. Effectiveness of
topic-specific infobuttons: a randomized controlled trial. J Am Med Inform Assoc. 2008
Nov-Dec;15(6):752-9. DOI: http://dx.doi.org/ 10.1197/jamia.M2725
4. Sievert M, Burhans D, Ward D, Jones BB, Bandy M, Carlson J, et al. Value of Health
Sciences Library Resources and Services to Health Care Providers in Medium and Large
60

Communities Across Two Mid-Continental States. Journal of Hospital Librarianship.
2011 2011/04/01;11(2):140-57. DOI: http://dx.doi.org/ 10.1080/15323269.2011.558882
5. Marshall JG, Sollenberger J, Easterby-Gannett S, Morgan LK, Klem ML, Cavanaugh
SK, et al. The value of library and information services in patient care: results of a
multisite study. J Med Libr Assoc. 2013 Jan;101(1):38-46. DOI: http://dx.doi.org/
10.3163/1536-5050.101.1.007
6. Shimizu T, Nemoto T, Tokuda Y. Effectiveness of a clinical knowledge support
system for reducing diagnostic errors in outpatient care in Japan: A retrospective study.
Int J Med Inform. 2018 Jan;109:1-4. DOI: http://dx.doi.org/
10.1016/j.ijmedinf.2017.09.010
7. Nelson EC, Mohr JJ, Batalden PB, Plume SK. Improving health care, Part 1: The
clinical value compass. Jt Comm J Qual Improv. 1996 Apr;22(4):243-58.
8. Isaac T, Zheng J, Jha A. Use of UpToDate and outcomes in US hospitals. J Hosp Med.
2012 Feb;7(2):85-90. DOI: http://dx.doi.org/ 10.1002/jhm.944
9. Association of Academic Health Sciences Libraries (AAHSL). Annual Statistics of
Medical School Libraries in the United States and Canada 2014-2015. Seattle, WA
Association of Academic Health Sciences Libraries (AAHSL), 2014-15 2016. Report
No.: 38.
10. Fiander M, McGowan J, Grad R, Pluye P, Hannes K, Labrecque M, et al.
Interventions to increase the use of electronic health information by healthcare
practitioners to improve clinical practice and patient outcomes. Cochrane Database Syst
Rev. 2015 Mar 14(3):Cd004749. DOI: http://dx.doi.org/
10.1002/14651858.CD004749.pub3
11. Weinstock MA, Chren M-M. Chapter 1. The Epidemiology and Burden of Skin
Disease. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K,
editors. Fitzpatrick's Dermatology in General Medicine, 8e. New York, NY: The
McGraw-Hill Companies; 2012.
12. Awadalla F, Rosenbaum DA, Camacho F, Fleischer AB, Jr., Feldman SR.
Dermatologic disease in family medicine. Fam Med. 2008 Jul-Aug;40(7):507-11.
13. Barnett ML, Song Z, Landon BE. Trends in physician referrals in the united states,
1999-2009. Arch Intern Med. 2012;172(2):163-70. DOI: http://dx.doi.org/
10.1001/archinternmed.2011.722

61

14. Martinka MJ, Crawford RI, Humphrey S. Clinical Recognition of Melanoma in
Dermatologists and Nondermatologists. J Cutan Med Surg. 2016 Nov;20(6):532-5. DOI:
http://dx.doi.org/ 10.1177/1203475415623513
15. Federman DG, Reid M, Feldman SR, Greenhoe J, Kirsner RS. The primary care
provider and the care of skin disease: the patient's perspective. Arch Dermatol. 2001
Jan;137(1):25-9.
16. Gulati A, Harwood CA, Rolph J, Pottinger E, McGregor JM, Goad N, et al. Is an
online skin cancer toolkit an effective way to educate primary care physicians about skin
cancer diagnosis and referral? J Eur Acad Dermatol Venereol. 2015 Nov;29(11):2152-9.
DOI: http://dx.doi.org/ 10.1111/jdv.13167
17. Swetter SM, Chang J, Shaub AR, Weinstock MA, Lewis ET, Asch SM. Primary
Care-Based Skin Cancer Screening in a Veterans Affairs Health Care System. JAMA
Dermatol. 2017 Aug 1;153(8):797-801. DOI: http://dx.doi.org/
10.1001/jamadermatol.2017.1324
18. Logical Images I. VisualDx 3445 Winton Pl. Suite 240, Rochester NY 14623:
Logical Images, Inc.; [10/22/2018]. Available from:
https://www.visualdx.com/visualdx/7/.
19. Rebedew D. VisualDx. Fam Pract Manag. 2015 Jan-Feb;22(1):33.
20. David CV, Chira S, Eells SJ, Ladrigan M, Papier A, Miller LG, et al. Diagnostic
accuracy in patients admitted to hospitals with cellulitis. Dermatol Online J. 2011 Mar
15;17(3):1.
21. Chou WY, Tien PT, Lin FY, Chiu PC. Application of visually based, computerised
diagnostic decision support system in dermatological medical education: a pilot study.
Postgrad Med J. 2016 Sep 02. DOI: http://dx.doi.org/ 10.1136/postgradmedj-2016134328
22. Hayes Richard J. MLH. Cluster Randomized Trials. Boca Raton: CRC Press; 2009.
23. Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG, et al.
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial
designers. J Clin Epidemiol. 2009 May;62(5):464-75. DOI: http://dx.doi.org/
10.1016/j.jclinepi.2008.12.011
24. Doig GS, Simpson F. Randomization and allocation concealment: a practical guide
for researchers. J Crit Care. 2005 Jun;20(2):187-91; discussion 91-3. DOI:
http://dx.doi.org/ 10.1016/j.jcrc.2005.04.005

62

25. Stull DE, Leidy NK, Parasuraman B, Chassany O. Optimal recall periods for patientreported outcomes: challenges and potential solutions. Curr Med Res Opin. 2009
Apr;25(4):929-42. DOI: http://dx.doi.org/ 10.1185/03007990902774765
26. Wiklund I. Assessment of patient-reported outcomes in clinical trials: the example of
health-related quality of life. Fundam Clin Pharmacol. 2004 Jun;18(3):351-63. DOI:
http://dx.doi.org/ 10.1111/j.1472-8206.2004.00234.x
27. Valderas JM, Kotzeva A, Espallargues M, Guyatt G, Ferrans CE, Halyard MY, et al.
The impact of measuring patient-reported outcomes in clinical practice: a systematic
review of the literature. Qual Life Res. 2008 Mar;17(2):179-93. DOI: http://dx.doi.org/
10.1007/s11136-007-9295-0
28. Revicki D, Feeny D. Journal of Patient-Reported Outcomes: aims and scope. Journal
of Patient-Reported Outcomes. 2017 September 12;1(1):6. DOI: http://dx.doi.org/
10.1186/s41687-017-0009-2
TRIAL REGISTRY: ClinicalTrials.gov: NCT02922738
AUTHOR CONTRIBUTIONS: MB and BL developed the study desgn and methods,
MB conducted participant recruitment and data collection, MB and BL analyzed the data,
interpreted it, and wrote and approved the final manuscript.

63

Barriers and Facilitators to Using Clinical Evidence Technology
in the Assessment of Skin Problems in Primary Care
3.1 Abstract
Background: A previous cluster-randomized controlled trial tested the effectiveness of a
clinical evidence technology (CET), VisualDx, for skin problems seen by primary care
providers (PCPs). Based on patient report, there was no effect on time to problem
resolution or return appointments.
Objective: The objective of this investigation was to explain, from the provider
perspective, why the CET did not make a difference in the clinical trial and to identify
barriers and facilitators to successful use of VisualDx.
Methods: We used a mixed methods study design. Providers from both arms completed a
survey about their use of VisualDx and information-seeking during and after the trial.
Active arm providers participated in interviews to explore their opinions and experiences
using VisualDx. Behavioral steps of the evidence-based medicine (EBM) paradigm
framed the analyses. The survey and interviews were conducted concurrently.
Results: PCPs found VisualDx easy to use (median 3 on a 1-4 scale), but found it only
somewhat useful (median 2 on a 1-4 scale). PCPs with fewer years in practice used it
more often and found it easier to use. Interviews identified facilitators and barriers to
using VisualDx. Facilitators included diagnostic uncertainty, positive attitude, ease of
access, utility for diagnosis and therapy decisions, and utility for patient communication.
Barriers included PCP confidence in dermatology, preference for other sources, interface
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difficulty, and retrieval of irrelevant diagnoses and images. Some PCPs reported positive
impacts on patient treatment and fewer referrals; others saw no difference.
PCPs found VisualDx easy to access, but some found the interface difficult to use. They
found it useful and relevant at times, but also frustrating and time-consuming. They used
other sources in addition to, or instead of, VisualDx.
Conclusion: PCPs did not perceive VisualDx as “useful” often enough for them to use it
frequently or exclusively, thereby reducing the likelihood of it making a difference in
patient-level outcomes such as problem resolution and return appointments.
3.2 Background
Studies show that clinicians who use clinical evidence technologies (CETs) to
answer clinical questions perceive that they change or confirm diagnoses and treatment
decisions, avoid medical errors, and improve their practice [1-3]. Obstacles to answering
clinical questions and information acquisition with CETs are also reported. Poor
technology access, lack of available evidence sources, lack of relevant evidence in chosen
source, time constraints, and lack of institutional support are described as reasons for
clinicians’ failure to use CETs in patient care [4-6].
Evidence-based medicine (EBM), defined as “the integration of best research
evidence with clinical expertise and patient values [7]” endorses the use of researchbased evidence found in medical journals, databases, and clinical topic summaries. In
practice, EBM outlines basic steps that clinicians must take to effectively find and apply
evidence. These steps may need to be executed quickly, often in a patient visit. The
behavioral steps outlined for EBM in practice are 1) Ask a clinical question, 2) Acquire
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available evidence, 3) Appraise and interpret it, and 4) Apply evidence with patient
values and preferences [8, 9].
3.3 Previous Study
VisualDx is a factual knowledge database and diagnostic tool that matches
patient symptoms with images to suggest likely diagnoses and management strategies
[10]. Research suggests that its use improved ER physicians’ knowledge and accuracy of
diagnosis for cellulitis [11], and diagnoses by dermatology residents and medical students
for other skin conditions [11, 12].
Use of VisualDx, a CET, by primary care providers (PCPs) was the intervention
in a 2016 cluster-randomized controlled trial (CRCT) [13]. In the CRCT, PCPs were
randomly assigned to use VisualDx or not. Their patients with skin complaints were
interviewed about the outcome of the care they received. The CET did not affect time to
resolution of symptoms or need for return appointments for the same problem in that
study.
3.4 Objective
The objective of this investigation was to 1) learn why VisualDx did not make a
difference in patient-level outcomes from the perspective of the clinicians, and 2), to
identify barriers and facilitators to the use of the CET as experienced by VisualDx users.
3.5 Study Design
We used a convergent, parallel, mixed methods design with a quantitative
survey and qualitative interviews. [14]. We combined data types to realize a more
complete analysis and interpretation when exploring the experiences and perspectives of
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the PCPS who used VisualDx, and to interpret their experience through a behavioral steps
model adapted from the EBM in practice steps.
3.6 Methods
The methods of the current study included a survey of all participant PCPs
(users and non-users of the CET VisualDx), and semi-structured interviews of PCPs in
the active arm (VisualDx users). PCPs from both arms completed a closed answer survey
on paper or online. Interview participants included only the active arm PCPs i.e. those
assigned to use the CET. The original trial and the current investigation took place at the
University of Vermont Medical Center [13]. The subjects included faculty and residents
in Family Medicine and Internal Medicine primary care clinics.
The behavioral steps of the EBM paradigm were used as a reference framework
to inform the data analyses and evaluate the success and failure of the CET as used by
PCPs. To realize a more in-depth understanding, we developed a six-step model of how
clinicians seek evidence, use a CET to answer patient care questions, and apply evidence
learned to patients. Thus, the model behavioral steps, for the current study were: (S1)
Recognize a clinical uncertainty, (S2) Decide to seek information, (S3) Navigate access
technologies, (S4) Use the CET interface and features, (S5) Appraise the information
found for relevance and quality, and (S6) Apply the evidence to and with the patient. In
this model, difficulty at any step could block proceeding to the next, thereby reducing the
likelihood of finding relevant, applicable information in the CET, and preventing an
impact on patient care. (See Figure 3.1.)
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Figure 3.1: Model of behavioral steps to use a CET for patient care

We organized results from the survey and interviews with the Steps model to
illustrate the barriers, and facilitators of CET use that the PCPs encountered.
3.6.1 Quantitative Data and Analysis
PCP demographic data and CET usage patterns were available from the CRCT
baseline survey. In the post-trial survey, PCPs answered questions based on their arm
during the trial. Questions specific to the VisualDx user arm included: frequency of
VisualDx use, proportion of skin patients for whom they referred to VisualDx, ease of
use, and usefulness. Control PCPs were asked if they had used VisualDx or other CETs at
all during the trial. All were asked if they had used VisualDx after the trial and which
CET resources, if any, they had used for skin problems in a recent month. (See Figure
3.2)
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Primary Care Provider Survey
VisualDx user Arm
During the study, how many times did you refer to VisualDx?
In what percent of skin problem patients did you refer to it?
How useful was VisualDx in diagnosing and treating patients?
Scale 1-4, 1. Not at all, 2. Occasionally, 3. Usually, 4. Always
How easy or difficult was it to find information you needed?
Scale 1-4, 1. Very difficult, 2. Somewhat difficult, 3. Somewhat
easy 4. Very easy
Non-VisualDx user (Control) Arm
During the study participation period (ending July 31 2016), did you refer to
VisualDx?
Yes/No
Both arms
How often have you referred to VisualDx since the trial ended?
In the last month, how many times did you see a patient for a skin problem?
In last month, how many times did you look for additional information to
support care for a patient skin problem.
In those times, what sources did you use?
[Check box] DynaMed, Google, Journal articles, PubMed/Medline,
UpToDate, Textbooks (electronic or print), VisualDx, Wikipedia, Not sure,
Other. If other, please list.
Figure 3.2: Questions in post-trial surveys of trial participants

The survey questions on perceived usefulness and ease of use were informed by the
Technology Acceptance model [16] All survey data were recorded with REDCap
electronic data capture tools [17], and analyzed with descriptive statistics in Stata version
14.2 [18]. The University of Vermont Institutional Review Board approved both the
original clinical trial and the current investigation.
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3.6.2 Qualitative Data and Analysis
The principal investigator (MB) conducted semi-structured in-person interviews
of active group PCPs to ascertain their experiences and opinions about using the CET
during and since the CRCT. (See Figure 3.3)
The interviews and surveys were conducted concurrently in February and March 2018.
Semi-structured Interview Outline
Please describe your experience of being (participating) in the study.
What was your experience like using VisualDx? (Your opinion of it?) (Prompt: how
useful? hard/easy to use?
How did you usually access VisualDx? (Prompt: Such as device/network/portal, EHR,
mobile)
How did you find your usual method? (Prompt hard/easy, fast, slow?
What difference did VisualDx make in an aspect of patient care?
Could you describe a time when it did make a difference or perhaps when you hoped it
would and it didn’t?
Do you use VisualDx now? What prompts you to use it or not?
What other information resources did you use then or do you use now for evidence for
skin problems?
What else you would like to tell me about using clinical information resources relevant
to dermatology or skin problems?
Figure 3.3: Semi-structured interviews outline

The interviews were recorded, transcribed, and coded using NVivo version 12 qualitative
analysis software [19]. The PI and two independent coders identified themes from the
interviews. Results were discussed and themes derived from the interview statements by
three reviewers. Final themes were decided by the PI with reviewer consensus. Themes
were organized for relevance within the behavioral steps model (Figure 3.1).

70

3.7 Results
3.7.1 Quantitative Survey Results
Twenty-one (66%) of 32 PCPs from the original trial participated in the survey: 13 of 17
from the active group, and 8 of 15 from control group (See Table 3.1).
Table 3.1: Characteristics of 21 post-trial survey participants

N
Sex (Male), n (%)
Resident during CRCT (vs. Attending), n
(%)
Family Med (vs. Internal Med), n (%)
Provider Education
Physician, n (%)
Advanced Practice Nurse, n (%)
Years in Practice
Median
Range
Used VisualDx during CRCT, n (%)
Times used VisualDx during CRCT
Median
Range
Used VisualDx since CRCT (yes), n (%)

All
21
10 (47%)
4 (10%)

Active
13
6 (46%)
4 (31%)

Control
8
4 (50%)
0

10 (47%)

5 (38%)

5 (63%)

20 (95%)
1 (5%)

13 (100%)
0

7 (88%)
1 (12%)

17
1-40
14 (67%)

12
1-40
13 (100%)

18
2-39
1 (12%)

14 (67%)

10
3-125
9 (70%)

----5 (63%)

Frequency of VisualDx Use
All active arm survey respondents reported using the CET multiple times during
the study, (median 10 times). Seven of eight control arm PCPs did not use it. This
response indicated general protocol fidelity, confirming that VisualDx users sought
answers in VisualDx, and that the control group, with one exception, did not use it.
Less than half (6 of 13) of VisualDx users reported using it with 50% or more of
their skin patients. The rather low median of 10 uses of the CET per provider, coupled
with low use per patient, suggests barriers to effectiveness at Steps 1 and 2.
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Ease of Using of VisualDx
The survey asked, “How easy or difficult was it to find information you
needed?” This question did not distinguish ease of getting to the CET (Step 3) from the
search and find step in the CET itself (Step 4). Ten respondents (76%) reported that the
CET was “somewhat easy” or “very easy” to use compared to three (24%) who found it
“somewhat difficult” or “difficult”. On balance, PCPs reported the CET relatively easy to
use.
Usefulness
The survey measured usefulness with the question “How useful was it?” Five
PCPs (38%) considered it “Usually useful” (3 on the 1-4 scale) while eight (62%), found
it “not at all” or “only occasionally” useful. None found it “Always/ almost always”
useful.
Three of seven (42%) in practice 6 or more years found it not at all useful. No one with 5
years or less practice found it “Not at all” useful. Responses to the “how useful” question
most closely mapped to behavioral Step 5, Appraisal for quality and relevance and Step
6, Apply to and with patient.
Frequency, Ease of Use, and Usefulness
Those who found the CET harder to use used it less often (median 6 times) and those
who found it easier to use used it more often (median 15). Those who found it harder to
use found it less useful. Those who found it easier to use were divided equally on
usefulness: 50% found it never or occasionally useful, 50% found it usually useful.
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Years in practice
Less experienced PCPs used the CET with at least half of their skin patients
more often than older providers (67% vs. 29%). They also used it more often (median 15
vs. 10) and found it easier to use. A higher proportion also found it more useful (50% vs.
29%). However, these differences were not statistically significant (See Table 3.2).
Table 3.2: Results for VisualDx frequency of use, ease of use, and usefulness comparing years in
practice

All

N
13
Median VisualDx Use in
10 (3-125)
trial, n (range)
Used VisualDx with
6 (46)
>50% of skin patients,
n (%)
Ease of use, n (%)
Harder
3 (23)
Easier
10 (77)
Usefulness, n (%)
Less useful
8 (62)
More useful
5 (38)
§
ɸ
Spearman Rank, Fisher’s Exact Test

Practice
Years
≤5
6
15 (5-30)

Practice
Years
>5
7
10 (3-125)

PValue

4 (67)

2 (29)

0.62ɸ

-0.29§

0.06ɸ
0 (0)
6 (100)

3 (43)
4 (57)

3 (50)
3 (50)

5 (71)
2 (29)

0.43ɸ

Usage of VisualDx and Other Resources Post-Trial
There was little difference between users and non-users who had referred to VisualDx
since the trial. Since the trial, 69% of PCPs in the active arm had used the CET,
compared to 63% in the control arm, a small and statistically insignificant difference (P=
0.9 by Fisher’s exact test). In a recent recalled month, UpToDate was used by 11,
VisualDx by 6, text-books by 6, Google by 4, and Epocrates and DynaMed by one each.
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3.7.2 Qualitative Interview Results
Eleven active group PCPs participated in interviews, including three residents
and eight attending physicians (See Table 3.3). Two active group PCPs who participated
in the post-trial survey did not participate in an interview.
Table 3.3: Profile of active group survey and interview participants’ status during CRCT

PCP code

Resident/ Attending

Specialty

Sex

Years in Practice

PCP01
PCP02
PCP03
PCP04
PCP05
PCP06
PCP07
PCP08
PCP09
PCP10

Resident
Attending
Attending
Attending
Attending
Attending
Resident
Resident
Attending
Attending

IM
FM
IM
IM
FM
IM
IM
IM
FM
IM

Female
Male
Male
Female
Female
Male
Female
Female
Female
Male

1
32
34
17
40
4
3
3
4
22

PCP11
PCP98 (survey only)
PCP99 (survey only)

Attending
Attending
Resident

FM
FM
IM

Male
Male
Female

24
12
1

We assigned themes to provider statements and noted where the statement fell in the
Steps framework based on the content of the statement. Eleven relevant themes included:
dermatology confidence, attitude or intention, time pressure, other sources, access, skills
needed, interface difficulty, diagnosis support, irrelevance, patient communication, and
impact on patient management. Within themes, facilitators were factors that promoted
use of VisualDx, or that had beneficial impact on the PCP practice or the patient. Barriers
were defined as inhibitors of use of the CET or deterrents to its usefulness and
effectiveness. (See Appendix V)
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Recognizing Uncertainty in Skin Disease (S1)
This step, recognizing uncertainty when a patient presents with a skin disease problem,
set the PCP on the path to seeking new information. Dermatology, especially diagnosis of
rashes, was recognized by providers as an area of frequent uncertainty in primary care.
The recognition of uncertainty in skin disease care signaled more openness or intention to
seek information; therefore, we considered it a facilitator of VisualDx use.
“There are certain areas, [like dermatology] where internists in particular, don't
have as much training and we tend to fall into…less rigorous ways approaching a
diagnosis.” PCP10
Several interviewees stated that because of their own uncertainty in dermatology,
evidence-based information resources were especially needed in that domain.
“[Dermatology] is way harder because we just don’t have the exposure. Also, so
much of it is how it looks rather than like a description of symptoms. So, I think
something like VisualDx is totally necessary.” PCP07
“[Dermatology] is an area that I feel I continue to work towards improvement in
versus some other areas where I feel very prepared and skilled…” PCP09
Self-described knowledge or confidence in dermatology was a barrier to informationseeking because highly confident PCPs recognized uncertainty less often and needed the
CET less. Physicians with 32 and 24 years’ experience noted their comfort with existing
knowledge.
“If it's a simple thing that you kind of deal with a lot and you feel like you know
what it is and how to treat it, then you obviously wouldn’t use the resource in that
situation.” PCP02
“There were certainly a lot of patients where I felt comfortable with what I
thought the problem was” PCP11
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Decision to Seek Information in VisualDx (S2)
This step encompasses the decision to act on an uncertainty by seeking answers
to patient-related questions. Themes of intention to obtain information and availability of
competing sources were included in this step.
A positive intention toward using VisualDx was a facilitator for continuing use of
the CET throughout the trial. Some PCPs recounted the specifics of their assigned
protocol as evidence of their intention and commitment to use the CET during the trial.
“When I had a patient that had a skin complaint, I was supposed to open VisualDx
and use it to come up with a diagnosis or treatment…I tried to be pretty diligent
about it.” PCP01
“I think I probably used it close to every time I saw a skin problem, unless it was
super obvious…But even then, I would look it up and use it to get ideas for
treatment recommendations.” PCP08
For some, being in the study was a benefit in itself and motivated them to use it. They
saw it a as a learning opportunity that could improve their practice.
“I was glad I was in the intervention arm of the study, because…it was motivation
for me to use it [VisualDx] more and see how it changed my practice…” PCP08
PCPs did not always look for answers even with uncertainty present. Time pressure in a
patient visit made pursuit of any information in VisualDx or other CET less likely.
“When you're already 45 minutes behind and you got patients waiting and
someone comes in with a goofy-looking rash, it's very easy to say "Well, I think
it's this, let's try it, if it doesn’t work call me back…” PCP10
Some PCPs anticipated that diagnosis search on the CET would be time consuming, so
they seldom used the differential diagnosis tool but did use the CET to find treatment
options.
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“You know, [VisualDx] is time consuming and…you're busy. It’s easier to get at
treatment than it is to get a differential because it just takes longer. And I was less
likely to do that [differential] part.” PCP02
Use of other resources instead of VisualDx was also a barrier at Step 2. PCPs felt that
colleagues or other resources would be faster or more convenient and so used them
instead of the CET despite their active arm protocol.
“I was working…next to a skilled, older practitioner. So often times my first
recourse would be going to him, asking him to take a look. So that may have
decreased my use… Sometimes I just used Google Images” PCP09
Several PCPs reported using VisualDx to reduce diagnosis uncertainty but another source
for treatment or management decisions.
“If I knew what the problem was…but wasn't sure how to manage it, I might use
UpToDate [more].” PCP11
Several providers reported using UpToDate for skin problem questions, even though it is
not specialized for skin problems.
“I used UpToDate quite frequently. And I used Micromedex quite frequently…I
don’t think my use of VisualDx changed my rates of use of those other
resources.” PCP08
Access to VisualDx (S3)
This step occurred when the PCP navigated the hospital network, medical library website,
or a mobile device to reach the CET. Based on the interviews, access through the
electronic medical record (EHR) was an important facilitator. All interviewees described
the EHR as virtually the only way they used VisualDx. The ubiquity of networked desktop computers in exam rooms and offices were additional facilitators. The mobile version
of the CET was available on smart phones and tablets, but no participant reported using it
for patient care.
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“I always went to it on a desktop through [EHR]. Never through the hospital
intranet. Never used the mobile. When I’m in clinic I don’t use my phone. We’re
always on the computer, writing the notes, or looking at vitals, looking at
meds…” PCP01
Easy point-of care access was essential for some to even consider using a CET.
“…It's difficult, for clinicians that are in a fast-paced clinical environment, to be
able to stop and reference things if you don't have it immediately at your
fingertips.” PCP11
One PCP developed problems accessing the resource after one month into the study and
never got back on track using the resource.
“[It was] moderately useful in the beginning but then, I couldn’t access it. I asked
for help…and maybe I got a response. But maybe I didn’t…follow the answer,
and I didn’t use it again.” PCP05
VisualDx Interface and Features (S4)
PCPs next step after navigating access was to utilize the CET’s interface and
features. Some found it easy to learn and use while others doubted their skill to use it
effectively. A majority stated that they found the CET easy to use, requiring only a slight
learning curve. This confirmed the survey results, particularly among those with 5 or
fewer years in practice.
“…Once I knew what I was doing, it wasn't hard to use.” PCP06
“I would say it's fairly easy…There was a small learning curve to…figure out the
best way to use it.” PCP08
Others found the interface a barrier and found the interactive diagnosis tool
difficult or unpredictable. Even though PCPs viewed a brief training tutorial, some felt
they lacked the skill to use it effectively and questioned whether they were at fault for not
getting better search results.
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“I remember staring at it saying, when I was trying to figure out what this rash
was, ‘Where do I put the information in?’. So, it wasn't as user-friendly for data
input.” PCP10
“The output is not always coming up with the most common causes…Or the
things I'm most likely to think it is…So I'm not sure if I’m just not putting in
enough [information]” PCP09
Appraise for Quality and Relevance (S5)
In step 5, the PCP evaluated or appraised the evidence presented by the CET for
quality and relevance to their information need. PCPs considered VisualDx as validated
by expert dermatologists and sufficiently reliable to serve as “best available” evidence.
Several noted that it was more reliable than images on an internet search engine.
“I had a lot of confidence that the material was accurate and properly edited or
authenticated by experts in the field. I didn't have any concerns about that.”
PCP03
“The problem with Google Images is [that] anybody…can upload a picture and
tag it with a diagnosis. At least VisualDx has been validated by somebody that
these pictures are the real deal.” PCP10
PCPs, especially those with fewer years in practice, found the CET’s’ interactive
diagnostic tool useful when they were “starting from scratch” with little idea of the
diagnosis. The ability to broaden the differential [diagnosis] was useful especially to
residents and those newer to practice.
“I did, on a few occasions, have no idea what I was looking at in the patient and
used it to try to figure it out.” PCP08
“…I would often look at a skin lesion or rash and have an idea…and then I would
put information into VisualDx and it would broaden my differential and
sometimes completely change my initial opinion.” PCP07
“…I had this young woman with…this rash on her back, I…thought maybe
psoriasis, and then used VisualDx. Based on what I found, it looked more like
pityriasis rosea so I went that way instead.” PCP08
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Even experienced physicians wished to expand the differential diagnosis at times.
“If something is really weird and I’m trying to figure out what are the possibilities
here, it certainly helps generate a list of possible conditions.” PCP10
Several experienced providers reported that the CET confirmed a diagnosis and enhanced
their diagnostic confidence.
“A niche for VisualDx is when you think you know what it is but you just want to
make sure you haven’t forgotten something.” PCP10
“I can definitely say it helped me feel…more confident about a diagnosis.”
PCP02
Although fewer PCPs reported using the CET for treatment decisions, those who
did found it current and useful.
“Treatment recommendations? I definitely used it for those. If I had tried the
usual things you try in the primary office…it was helpful to see some of the other
treatment options…available on there.” PCP01
An experienced PCP found the treatment recommendations especially relevant for
updating his usual practice.
“One case was a fungal infection on the nails…There was a new topical treatment
option that had recently been FDA-approved and I hadn’t used it before.” PCP02
On the other hand, the barrier of useless or irrelevant information in the CET
came up frequently.
“Just as frequently as I found that it was helpful, I found that it was not helpful at
all…I mostly got a lot of extraneous information and things that…weren't
appropriate for what I was looking for…So some of that time using it was
wasted” PCP08
Some experienced clinicians felt that broadening the differential was not useful for them.
They preferred a tool that would help them narrow or confirm the diagnosis. VisualDx
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was not as useful for that because the diagnoses and images retrieved were excessively
broad.
“So, at least for my level of experience, it didn't offer me a whole lot in terms of
narrowing my differential diagnosis. It was a lot more about broadening it, and
I'm not sure if that was helpful to me.” PCP03
There was often too much or irrelevant information. The information retrieved needed to
be sifted or a new search launched which consumed valuable time.
“If you put basal cell carcinoma into VisualDx, it’s a thousand pictures of every
possible way a basal cell carcinoma can show up - which can be misleading,
because it's not showing you what the typical ones are. So…it's almost too much
information.” PCP03
I remember getting more hits back…a lot more diagnoses - than I was expecting - some of which didn't even look close to what I described.” PCP10
A barrier to this CET making a difference was that PCPs used it as one tool
among others rather than relying in it alone. Some PCPs used VisualDx less because they
preferred other sources.
“I have a favorite dermatology book that I use like I would use VisualDx.” PCP10
“If there was something I was worried about or I didn't know, I'd look in
VisualDx but then I'd really rely on [a colleague]: Hey do you mind coming to
look at this?” PCP07
“…If I thought of something, I’d look it up on UpToDate [also] and see if the
pictures and descriptions matched” PCP06
Apply to and with Patient (S6)
In this step, the PCP applied the information from VisualDx to the patient.
Applicable themes included patient communication, management, i.e. treatment or
referrals, and “no difference” (no impact on management).
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Most PCPs found VisualDx useful for communication, decision agreement, and
building rapport with patients. Several said it helped show patients how their condition
had changed or improved. Several PCPs reported that they shared what they learned on
the CET with the patients to help explain their condition.
“[I used it with patients] a couple of times, especially if they had something that
went away; then they could say "Oh it did look like that", kind of self-report. [It
was helpful for] patient communication and education, absolutely.” PCP04
“If you are able to say, “This is really just eczema and this is what eczema looks
like on other people, and it’s just like yours”, it gives you a kind of rapport with
them.” PCP01
Some reviewed alternative diagnoses and images with patients during the visit to reach
agreement with them.
“I would open it up on the computer in the patient’s room oftentimes, and go
through it [all] with them.” PCP06
“I would look at VisualDx and it would give me four additional ideas. So, then I
would talk to the patient more, come up with a diagnosis that I thought was likely
enough…to act on.” PCP08
The PCPs who used images with patients found them helpful for communication and
understanding.
“…If you can use a visual to show somebody and say, "Oh this looks like really
what you have," they gain a little bit more confidence.” PCP09
Some PCPs reported that VisualDx influenced therapy and referral decisions,
and advice to patients and caregivers.
“A patient came in and he was pretty convinced he had poison ivy and I was
pretty convinced that he didn’t…I ended up using [VisualDx], and he was right. I
would have treated it differently had I not opened it and used some of the pictures
to help.” PCP01
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Some PCPs stated that using the CET altered their referral patterns, prompting some
referrals and avoiding others. Those making fewer referrals cited having more confidence
as the reason.
“A lady came in with something strange on her eyes and we couldn’t figure out
what it was. Based on using VisualDx I came up with something I hadn’t
considered that was treated quite differently. That did prompt a referral to
dermatology.” PCP01
“I think it changed my rate of dermatology referrals because I willing to diagnose
skin conditions with…more confidence and to act on those diagnoses.” PCP08
Despite positive examples of application to the patient and differences in management,
others did not recall any impact that using the CET made.
“Care difference? I would have to say no, that it didn't really offer me a different
path forward”. PCP03
“I can't think of a particular instance where it clinched it for me or made a clinical
decision distinction or difference. It was more of a tool that I used to augment
whatever I was looking into otherwise.” PCP09
3.8 Discussion
3.8.1 Barriers
This mixed methods study identified facilitators and barriers to effective use of
VisualDx and its impact on PCP decisions and patient care management. Although there
were facilitators and benefits, PCPs experienced significant barriers to using the CET.
Barriers included lack of perceived need, time pressure, use of other resources, difficulty
of interface, irrelevance of information retrieved, and low impact on care management.
The greatest single barrier to the CET use appears to have been the frequency of
retrieving irrelevant information (“about half the time”), and the frustration and wasted
time that engendered. Several held the view that the CET had no impact on case
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management. In the survey, more PCPs found it “never” or “occasionally” than
“usually”. Similarly, lack of relevant information retrieved [4, 21] and insufficient time
have been described in previous studies [20].
Seeking information from multiple sources is typical information-seeking
behavior for clinicians. [1, 21]. In the current study, PCPs also utilized multiple sources,
but they preferred CETs easily available from within in the EHR or at the point-of-care
including UpToDate, Google Images, and print textbooks. Although there is an intrinsic
value to having multiple sources, their presence served as a barrier to the use of VisualDx
and, when they are effective, decreases the impact that the CET has on clinical outcomes.
3.8.2 Facilitators and Benefits
Positive intention to use the CET and accessibility via the EHR facilitated use.
PCPs did not often use other dermatology-relevant CETs, such as electronic dermatology
text-books, MEDLINE and dermatology journals available to them on the medical library
website because they were less convenient and took them out of the EHR environment.
Expansion of the -differential diagnosis, and confirmation of diagnostic
decisions were benefits expressed in the interviews. Diagnosis support was
“occasionally” or “usually” useful. PCPs in practice five years or less, including
residents, appreciated the differential diagnostic support more than senior providers.
Those in practice longer preferred to narrow or confirm a diagnosis more, but they were
sometimes disappointed with excessive results.
Successful use of the CET for patient communication and shared decisionmaking at Step 6 was an unexpected benefit. This benefit could have affected patient
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satisfaction with care, an outcome that was not evaluated in this investigation but could
be evaluated in future research.
3.8.3 Impact on Patient Management
PCPs recalled cases when use of VisualDx made a difference in care
management in terms of treatment and referrals (Step 6). The CET altered referral
patterns, though the differences were in both directions: prompting some referrals and
avoiding others. Use of the CET may have resulted in more appropriate referrals, but not
a reduction in the overall number of return appointments, an outcome measured in the
clinical trial. The interviews confirmed that, at least at times, PCPs believed there were
practice improvements after using the CET.
According to a large qualitative study of clinicians, efficiency, defined as brief
time to find information and the high relevance of information found, was the most
important factor in provider satisfaction with CETs at the point of care [22]. By this
criterion, the CET studied here could improve efficiency because of its perceived
convenient access through the EHR and its perceived ease of use, thus overcoming
barriers of time and access to evidence. On the other hand, the need or habit of clinicians
to use other resources and the occasions when information retrieved was irrelevant
contributed to inefficiency.
3.8.4 Strengths and Limitations of this Study
This investigation extended previous work on one CET’s value in the Primary
Care dermatology domain. The population studied included PCPs with varying
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experience and backgrounds. Mixed methods enriched our understanding of the users’
experiences and allowed us to compare results obtained by different methods.
The study took place in one academic health center thereby limiting
generalizability to other settings. Outcomes reported were the view of the providers and
not verified by patients or other data sources. Although recall errors are possible in any
retrospective report, all participants recalled their participation and responded to survey
and interview questions without difficulty.
3.9 Conclusions
This mixed methods investigation identified facilitators and barriers to PCPs use
of a CET for dermatological problems that may help explain the results of the prior
randomized trial. Despite offering high quality information and interactive diagnostic
features, VisualDx was not sufficiently easy to use, or consistently useful enough to
motivate PCPs to use it frequently or exclusively. Therefore, it did not make a
measurable difference in provider acceptance or patient outcomes. This assessment could
be used by medical informaticists and medical librarians responsible for acquisition and
implementation of dermatology CETs in academic medical center settings.
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APPENDICES
Appendix I : Provider Eligibility and Baseline Survey
This survey was administered to Primary Care Providers through REDCap following
their consent to participate.
Eligibility Screening Questions:
1.
o
o
o
o

What is your medical or professional degree?
Physician
Physician Assistant
Advanced Practice Nurse
None of the above

2. Are you currently seeing patients at a UVMMC Family Medicine or Primary Care
Internal Medicine Clinic?
o Yes
o No

3. Do you agree to adhere to the procedures of the study depending on the group you
are randomized to?
o Yes
o No
o Not sure. Please call me.

Answers to Q 1. must be Physician, Physician Assistant, or Advanced Practice
Nurse. Answer to Q. 2. must be yes. Answer to Q. 3. must be yes to be enrolled in the
study and continue to baseline survey.

Baseline Survey in the Information for Skin Problems in Primary Care Study.
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1. In the last month, how often did you refer to a print or electronic information source to
support patient care?
o
o
o
o
o

None at all
1-3
4-6
7-9
10 or more times

2. Which information sources did you use to support patient care? (Check all that apply.)
□
□
□
□
□
□
□
□
□

DynaMed
Google
Journal Articles
PubMed/Medline
UpToDate
Textbooks (electronic or print)
Visual Dx
Not sure/don't remember
Other

3A. If other, please specify.
__________________________________
The next three questions refer to when you saw patients for skin problems.

4. In the last month, how many times did you see a patient for a skin problem?
o
o
o
o
o

None at all
1-3
4-6
7-9
10 or more times

5. In the last month, how many times did you look for additional information to support
care for a patient skin problem?
o None at all
o 1-3
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o 4-6
o 7-9
o 10 or more times
6. Recalling those times when you sought information for a patient skin problem, what
sources did you use? (Select all that apply.)
□
□
□
□
□
□
□
□
□

DynaMed
Google
Journal Articles
PubMed/Medline
UpToDate
Textbooks (electronic or print)
Visual Dx
Not sure/don't remember
Other
6A. If other please specify: __________________________________

Information About You
7. What year did you graduate from professional school? _____________
8. Are you in a residency program?
o Yes
o No
9. Primary Care Specialty
o Family Medicine
o Internal Medicine
o Other
9A. If other please specify: __________________________________
10. Your usual practice location:
o
o
o
o
o
o

Family Medicine Berlin
Family Medicine Colchester
Family Medicine Hinesburg
Family Medicine Milton
Family Medicine South Burlington
Urgent Care Colchester
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o
o
o
o

Adult Primary Care South Burlington
Adult Primary Care Essex
Adult Primary Care Burlington
Adult Primary Care Williston

11. What is your gender?
o Female
o Male
o Other
12. Please let us know here if you have any questions or comments.
__________________________________________
We will email you in a few days with an orientation for the procedures for your
randomized group.
End of Provider baseline survey
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Appendix II: PCP Active Group Educational Tutorial

Information for Skin Problems
in Primary Care Study

Provider Orientation and Procedures
Center for Clinical and Translational Science
University of Vermont

Welcome
Thank you for agreeing to participate in this
research.
This learning module will help you participate in the
study in an efficient and effective way.
The module will take about 5 minutes to review.
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Your Group Protocol
▪ Your group protocol is to refer to VisualDx, a dermatology
information source, when you see a patient for a skin
problem.
▪ If you have any uncertainty about appearance, diagnosis,
treatment, or prognosis of a skin problem or want to share
information with a patient, please use VisualDx.

Your Group Protocol
▪ The referral to VisualDx related to the patient skin
problem could be anytime before, during, or after a visit,
▪ The lookup could be brief to confirm something you
already know or to share an image or description with
your patient.
▪ The lookup would be longer if you have more concern
about the diagnosis or treatment of the problem.
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What Is VisualDx?
▪ VisualDx is a clinical knowledge and diagnostic support
resource that is licensed by UVM Medical Library to
support providers and patient care.
▪ It contains over 100,000 images of skin and other visible
conditions.

How Do I Access VisualDx?
There are 4 main ways:
▪ PRISM
▪ UVMMC Intranet Desktop

▪ Dana Medical Library website
▪ Your Mobile Device (app)
The next few slides will provide instruction on each access method.
.
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From the PRISM Home Screen
▪ Click the blue EPIC button at
the top left of PRISM screen
for a dropdown menu
▪ Click on Reference Links for
another dropdown menu
▪ Click on VisualDx

From the UVMMC Intranet
▪ On the UVMMC intranet home page
▪ Look for the Applications box and click the
General button
▪ Click on Dana Medical Library
▪ This will bring you to the Dana Library
website
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From the Dana Library Website
▪ Click the Articles and Database link
▪ Scroll down to the Clinical
Databases section in the left hand
column
▪ Click the VisualDx link
▪ Bookmark the page for convenience.
▪ Your most direct link to VisualDx is
through PRISM or Mobile app.

To Access VisualDx from your Mobile Device
▪ Go to PRISM or Dana Library website
▪ Go to VisualDx
▪ Directions for registering and
downloading the app are on the opening
page. Click on the icon.
▪ Video: http://www.visualdx.com/videotutorials/visualdx-mobile

The next two slides introduce ways to use VisualDx.
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How to use VisualDx: Differential Builder
▪ The differential builder is a
distinguishing feature of VisualDx.
Click on the blue Differential Builder
button to start.
▪ The builder will prompt you for
patient age, lesion type, body
location, appearance, and other
findings.
▪ VisualDx will display images and
diagnoses that match all the criteria
you selected.

VisualDx Features
▪Please take time to become familiar and fluent with using VisualDx.
▪ For more information, see the educational videos at the VisualDx
website: http://www.visualdx.com/visualdx-videos/5-minuteoverview-and-demo
▪If you have any problem using VisualDx easily, contact Gary
Atwood MLS, Study Team member and Education Librarian at
Dana Medical Library at Gary.Atwood@uvm.edu or 656-4488.
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Other Procedures:
What Happens After the
Patient Visit?
▪ PI identifies your eligible
patients in PRISM.
▪ Study team sends each patient
a letter over your name
informing them of the study.
▪ We ask that you provide your
signature to include on the
letters to your patients.

Additional Information about the PCP Role
▪ Both PCPs and patients are subjects in this study.
▪ 30 or more providers and 300 patients, an average of 10 patients per
provider, will participate.
▪ We will contact you every 2 weeks by email or phone to update you on
the progress of the study and answer any questions.
▪ We will notify you when we have recruited enough patients so that you no
longer need to follow the protocol.
▪ Anticipated duration of your involvement is 6 – 12 weeks.
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Questions or concerns?
If you have any problem using VisualDx easily, contact Gary Atwood MLS, Study Team
member and Education Librarian at Dana Medical Library at Gary.Atwood@uvm.edu or
656-4488.
If you have a concern about the study or its procedures, please contact the Principal
Investigator, Marianne Burke, MA-L, at the Center for Clinical and Translational Science,
4th fl. Given Courtyard South, UVM, by email mburke@uvm.edu or phone 802-236-0075.
This research protocol was approved by the UVM/UVMMC Committee on Human Subjects
Research, June 10, 2015.
Thank you for completing this module. We recommend you download it for your reference.
Please return to the REDCap survey page to answer 1 question.
Center for Clinical and Translational Science
University of Vermont
656- 4560
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Appendix III: PCP Control Group Educational Tutorial

Information for Skin Problems
in Primary Care Study

Provider Orientation and Procedures
Center for Clinical and Translational Science
University of Vermont

Welcome
Thank you for agreeing to participate in this
research.
This learning module will help you participate in the
study in an efficient and effective way.

The module will take about 5 minutes to review.
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Your Group Protocol
▪ You will see patients for skin problems as you normally
do.
▪ Note the skin problem discussed or treated during the visit
in the PRISM patient record as you normally would.

Your Group Protocol
▪ According to your group protocol, you may choose to refer
to an additional information source concerning the skin
problem or not.
▪ Refer to any textbook or electronic resource as you
normally would or not.
▪ Except – Do not refer to VisualDx.
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Other Procedures: What
Happens After the
Patient Visit?
▪ PI identifies your eligible
patients in PRISM
▪ Study team sends each patient
a letter over your name
informing them of the study.
▪ We ask you to provide your
signature to include on the
letters to your patients.

Additional Information about the PCP Role
▪ Both PCPs and patients are subjects in this study.
▪ 30 or more providers and 300 patients, an average of 10 patients per
provider, will participate.
▪ We will contact you every 2 weeks by email or phone to update you on the
progress of the study and answer any questions.
▪ We will notify you when we have recruited enough patients so that you no
longer need to follow the protocol.
▪ Anticipated duration of your involvement is 6 - 12 weeks.
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Access to Clinical Knowledge Resources
Dana Medical Library provides access to electronic clinical
knowledge resources to support evidence-based patient care:
• Medical research journals.
• Medical e-text books in primary care and specialties.
• PubMed database with links to full text journal articles
• Mobile clinical apps.
You can access these resources from many different
locations.

FYI: How to Access Clinical Information Sources
There are 3 main ways:

▪ PRISM
▪ UVMMC Intranet Desktop

▪ Dana Medical Library website

The next few slides will provide instruction on each access method
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Access From PRISM
▪ Click the EPIC button

▪ Click on Reference Links for menu
▪ Click on Dana Library Main to
connect to the library’s web site.

▪ UpToDate and Micromedex are
also available here.
▪ Do not use VisualDX.

From the UVMMC Intranet
▪ Log in with M number
▪ On the UVMMC intranet home page
▪ http://intranet.fletcherallen.org
▪ Look for the Applications box and click the
General button
▪ Click on Dana Medical Library
▪ This will bring you to the Dana Library
website
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Access from the Dana Medical Library Web Site
http://library.uvm.edu/dana
▪ Click on PubMed etc.
▪ OR Click the Articles and
Databases link.
▪ Scroll down to the Clinical
Databases section in the left hand
column.
▪ Find multiple clinical information
resources.
▪ From Off Campus: Log on using M
number and password.

Questions or concerns?
If you have any problems referring to library resources easily, contact Gary Atwood MLS,
Study Team member and Education Librarian at Dana Medical Library at
Gary.Atwood@uvm.edu or 802-656-4488.
If you have a concern with any aspect of the study protocol please contact the Principal
Investigator, Marianne Burke at mburke@uvm.edu or phone 802-236-0075.
This research protocol was approved by the UVM/UVMMC Committee on Human Subjects
Research, June 10, 2015.
Thank you for completing this module. We recommend you download it for your
reference. Please return to the REDCap survey page to answer 1 question.

Center for Clinical and Translational Science
University of Vermont
656-4560
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Appendix IV: Patient Interview Data Collection Instruments
Patient telephone interview/Questionnaire at ~30 days after index visit for the skin
problem. Study team investigators including trained research assistants reached identified
eligible patients by telephone 30 days or after post the index visit for the skin problem.
After review of the lay summary, and verbal consent from the patient, the following
interview was conducted.
1. Our records show that you saw (provider name) for a skin problem about (date of
visit). Does that sound right?
o Yes – Go to question 2
o No – If patient cannot recall the problem or the visit, call is ended and patient is
ineligible (dis-enrolled).
2. Is (provider name) your usual primary care doctor?
o Yes
o No
3. Since you saw (provider name) for the skin problem last month have you gone back to
him/her or to any other doctor for a follow-up appointment for this same problem?
o Yes – Go to question 4
o No – Go to question 6
3A. How many other appointments did you have?
__________________________________
3B. What kind of doctor did you see for the follow up appointment?
□ Primary Care
□ Dermatologist
□ Other
3C. If other, what kind? __________________________________
4. Since that visit with (provider name), would you say the skin problem is:
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o
o
o
o

All Better If all better Go to 4A, 4B, 4C,4D
Improved – GO to 5
Unchanged – GO to 5
Worse – GO to 5
4A. About how long after that visit did it take to be all better?
______________________________
4B. How many days or weeks after the appointment was it all better?
__________________________________
4C. Would you say that this time frame is exact or approximate?
o exact
o approximate
4D. If it's easier, thinking back from today, how many days or weeks ago
did you think the problem was all better? [Answer could be in days, weeks, or
a date.]
__________________________________
After patient answers 4A, or 4B, or 4C with enough clarity to determine
number of days - Go to Question 6.

5. Do you plan to see a provider (of any kind) again for this same skin problem?
Yes – GO to 5A
No – GO to 6
5A. What type of doctor will you see?
□ Primary Care
□ Dermatologist
□ Other
5B. If other, what type? __________________________________
6. Thank you. Now, I'd like to ask a couple of questions about you.
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How old are you? __________________________________
7. What is your sex?
o male
o female
o other
After Question 7, Go to End call 1 or End call 2 depending on problem status.
End call 1: Patients who were “All Better”
Thank you for helping with this research. I have all I need and won't need to call you
again.
Do you have any questions or comments?
(Record if any)_________
Thank you for your participation. Goodbye.
End call 2: Patients who were improved unchanged or worse.
We're coming to the end of questions today. I'll call you again in about 4 weeks to see if
anything about the skin problem has changed. Thank you for your participation.
------------------------------------------------------------------------------------------------------------

60 Day or Second Patient Telephone Interview

1. Hello (patient’s first name) (patient’s last name). This is (caller name) from the UVM
Medical Center research on skin problems. We spoke with you a month ago about a skin
problem you saw Dr. (provider name) for. Do you remember talking with us?
o Yes
o No
2. When we spoke with you before, you described the problem as (problem status:
Improved, Unchanged or Worse). Does that sound right?
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o Yes
o No
3. Since I (or team member name) spoke with you before on (date of call) about the skin
problem visit, have you gone back to Dr. (provider name) or any other provider for this
same problem?
o Yes --- GO 3A and 3B
o No – Go to 4
3A. Since we spoke with you last time, how many appointments have you had for this
same problem? __________________________________
3B. What type of doctor did you see for this appointment(s)?
□ Primary Care
□ Dermatologist
□ Other
If other, what type?
__________________________________
4. Since that (First) visit with Dr. (provider name) and our conversation last month would
you say the condition is:
o
o
o
o

All Better ---If all better, go to 4A,4B, or 4C,4D
Improved ---Go to 5
Unchanged ---Go to 5
Worse ---Go to 5

4A. When did you realize the skin problem was all better? (Look at calendar try to
approximate days after call.)
__________________________________
4B. Looking at a calendar, that was about ( day/date) about _____(days Time) after
we talked
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__________________________________
4C. If it's easier, thinking back from today, can you recall how long ago you realized
the problem was all better? When was that?
__________________________________
4D. Would you say that number of days is exact or approximate?
o Exact number of days
o Approximate number of days
After determining the days since index visit or date (all better), GO to End Call 1
5. Do you plan to see a doctor or health care provider again for this condition?
o Yes – Go to 5A
o No - Go to End Call 2
5A. What type of doctor are you planning to see next?
□ Primary Care
□ Dermatologist
□ Other
If other, what type?
Go to End Call 2
End Call 1: Thank you for helping with this research.
I have all I need and won't need to call you again. Do you have any questions or
comments?
__________________________________
End Call 2: We're coming to the end of questions today. I'll call you again in about 4
weeks to see if anything about the skin problem has changed.
---------------------------------------------------------------------------------------------------90 Day (Final) Patient Questionnaire
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Hello (patient’s first name) I'm calling from the University of Vermont Medical Center
about the skin problems study.
I (or one of my team members called you about (3 or 4) weeks ago with questions about
what happened with a skin problem you saw doctor (provider name) for.
1. Do you remember?
o Yes
o No
2. When we spoke with you before said the problem was... INTERVIEWER SAYS
WHICH (improved, unchanged, or worse) Does that sound right?
o Yes
o No
3. Since I (my team member) spoke with you before (4 weeks ago) (date of call) about
your skin problem visit, have you gone back to any other doctor or provider for this same
problem?
o Yes -- GO to 3A-C
o No -- GO to 4
3A. How many follow up appointments?
__________________________________
3B. What type of doctor did you see for this appointment(s)?
□ Primary Care
□ Dermatologist
□ Other
3C. If other, what type? __________________________________
4. I'm going to ask you how the skin problem is doing.
Since that first visit with Dr. (provider name) and our conversation last
month would you say the condition is:
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o
o
o
o

All Better GO to 4A-D
Improved –GO to 5
Unchanged – GO to 5
Worse – GO to 5

4A. So about when did you realize the skin problem was all better?
__________________________________
4B. Looking at a calendar, that was about (suggest day/date) That was about
_____(Time) after we talked.
__________________________________
4C. If it's easier, thinking back from today, can you recall how long ago you
realized the problem was all better? When was that?
__________________________________
4D. Would you say that number of days is exact or approximate?
o exact
o approximate
GO to 5 End Call
5. End Call (All):
We have come to the end of the call and your participation in the study. Thank you so
much for your help. Do you have any questions or comments before we end the call?
(Record comments if any)________________________
Again, thank you very much. Goodbye
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Appendix V: Schema of Themes with Exemplar Quotations and Relevant
Behavioral Step and Barrier or Facilitator Effect
Theme

PCP Exemplar Quotations (Years in Practice)

Step#:
Effect

Knowledge
confidence
Attitude and
Intention

“There were a lot of patients where I felt comfortable with what the
problem was.” PCP11 (24 yrs.)
“I think I used it close to every time I saw a skin problem, unless it
was super obvious…But even then, I would use it to get treatment
recommendations. PCP08 (3 yrs.)
“When you are already 45 minutes behind schedule and someone
comes in with an [odd] rash, “It’s easy to say, I think it’s this, try it,
if it doesn’t work call me back”. PCP10 (22 yrs.)
“I was next to a skilled older practitioner so my first recourse might
be to go to him. So that may have decreased my use” PCP09 (4 yrs.)

S1: Barrier

“I have a favorite dermatology book I use like I would use
VisualDx.” PCP10 (22 yrs.)
“If I knew what the [diagnosis] was but didn’t know how to manage
it, I might use UpToDate [more].” PCP11 (24 yrs.)
“If I’m seeing patients, I’m already in the EMR, and VisualDx is
there. It’s easy to find. 99% of the time that’s what I’d do.” PCP11
(24yrs.)
“I remember staring at it saying, “Where do I put the information
in?” So it wasn’t as user friendly for data input” PCP10 (22yrs.)
“I did, on a few occasions have no idea what I was looking at in a
patient, and used [VisualDx]…to figure it out” PCP08 (3 yrs.)

S5: Barrier

Time

Other sources

Other sources
Other sources
Technology:
EMR access
Technology:
CET interface
Diagnosis:
expand
differential
Diagnosis:
confirm
Usefulness:
Irrelevance
Patient
communication
Patient
agreement
Usefulness: No
Difference

“I can definitely say it helped me feel more confident about a
diagnosis.” PCP02 (32 yrs.)
“If you put basal cell carcinoma in VisualDx, it’s a thousand
pictures of every possible way it can show up. It’s not showing the
typical ones” PCP03 (34 yrs.)
“I used it with patients, especially if they had something that went
away; then they could say,” Oh, it did look like that”. Helpful for
patient communication? Absolutely.” PCP04 (17 yrs.)
“I would open it up in the patient room oftentimes, and go through it
[all] with them.” PCP06 (4yrs.)
I can't think of a particular instance where it clinched it for me or
made a clinical decision distinction or difference. It was more of a
tool that I used to augment whatever I was looking into.” PCP09 (4
yrs.)

122

S2:
Facilitator
S1, S2
Barrier
S2: Barrier

S5: Barrier
S3:
Facilitator
S4: Barrier
S5:
Facilitator
(Benefit)
S5:
Facilitator
(Benefit)
S5 Barrier

S6
(Facilitator)
Benefit
S6
(Facilitator)
Benefit
S5, S6
Barrier

